Independence Holding (IHC) 10-Q 9 Aug 21 2021 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2021	Aug. 07, 2021
Details
Registrant CIK	0000701869
Fiscal Year End	--12-31
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2021
Document Transition Report	false
Entity File Number	001-32244
Entity Registrant Name	INDEPENDENCE HOLDING COMPANY
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	58-1407235
Entity Address, Address Line One	96 CUMMINGS POINT ROAD
Entity Address, City or Town	STAMFORD
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06902
City Area Code	203
Local Phone Number	358-8000
Title of 12(b) Security	Common Stock, $1.00 par value
Trading Symbol	IHC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		14,644,389
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Investments
Short-term Investments	$ 1,550	$ 1,568
Securities Purchased under Agreements to Resell	70,323	33,038
Debt Securities, Available-for-sale	183,709	210,719
Equity Securities, FV-NI, Current	0	1,753
Other Investments	2,022	1,928
Investments	257,604	249,006
Cash and Cash Equivalents, at Carrying Value	22,834	31,923
Equity Method Investments	33,762	0
Premiums Receivable, Net	10,950	9,981
Reinsurance Recoverables, Including Reinsurance Premium Paid	354,735	357,237
Goodwill	12,486	12,486
Escrow Deposit	78,779	0
Other Assets	29,864	46,832
Disposal Group, Including Discontinued Operation, Assets	416,162	375,691
Assets, Total	1,217,176	1,083,156
Liabilities
Liability for Claims and Claims Adjustment Expense	127,815	132,957
Liability for Future Policy Benefit, before Reinsurance	196,026	198,086
Deposit Contracts, Liabilities	142,155	141,376
Unearned Premiums	1,763	1,952
Policyholder Account Balance	11,988	12,001
Reinsurance Payable	2,242	3,872
Other Liabilities	66,519	44,855
Disposal Group, Including Discontinued Operation, Liabilities	120,180	75,939
Liabilities	668,688	611,038
Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount	0	2,312
TOTAL LIABILITIES AND EQUITY	1,217,176	1,083,156
STOCKHOLDERS' EQUITY:
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	18,625	18,625
Additional Paid in Capital, Common Stock	125,653	124,757
Accumulated Other Comprehensive Income (Loss), Net of Tax	3,220	4,197
Treasury stock, at cost; 3,981,069 and 3,982,411 shares	77,189	77,088
Retained Earnings (Accumulated Deficit)	478,139	399,273
TOTAL IHC STOCKHOLDERS' EQUITY	548,448	469,764
Stockholders' Equity Attributable to Noncontrolling Interest	40	42
TOTAL EQUITY	$ 548,488	$ 469,806

Consolidated Balance Sheets - P

Consolidated Balance Sheets - Parenthetical - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Details
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Shares Authorized	100,000	100,000
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 1	$ 1
Common Stock, Shares Authorized	23,000,000	23,000,000
Common Stock, Shares, Issued	18,625,458	18,625,458
Common Stock, Shares, Outstanding	14,644,389	14,643,047
Treasury Stock, Shares	3,981,069	3,982,411

Consolidated Income Statement

Consolidated Income Statement - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenues
Premiums Earned, Net	$ 42,451	$ 49,138	$ 86,023	$ 99,804
Net Investment Income	1,651	2,329	3,452	4,828
Insurance Commissions and Fees	4,944	3,907	11,079	7,341
Other Income	410	807	1,026	1,432
Gain (Loss) on Investments	(126)	274	91	117
Revenues	49,330	56,455	101,671	113,522
Operating Expenses
Policyholder Benefits and Claims Incurred, Net	17,192	21,339	39,113	47,628
Selling, General and Administrative Expense	32,842	37,974	63,602	69,034
Benefits, Losses and Expenses	50,034	59,313	102,715	116,662
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(704)	(2,858)	(1,044)	(3,140)
Income Tax Expense (Benefit)	(267)	(1,066)	(430)	(1,187)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	(437)	(1,792)	(614)	(1,953)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	92,375	3,594	99,574	9,243
Discontinued Operation, Tax Effect of Discontinued Operation	15,570	1,264	17,026	2,430
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	76,805	2,330	82,548	6,813
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	76,368	538	81,934	4,860
Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest	(1)	43	(2)	34
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	(102)	74	(156)	127
Net Income (Loss) Attributable to Parent	$ 76,471	$ 421	$ 82,092	$ 4,699
Earnings Per Share, Basic
Income (Loss) from Continuing Operations, Per Basic Share	$ (0.03)	$ (0.12)	$ (0.04)	$ (0.13)
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share	5.25	0.15	5.65	0.45
Earnings Per Share, Basic	$ 5.22	$ 0.03	$ 5.61	$ 0.32
Weighted Average Number of Shares Outstanding, Basic	14,642	14,765	14,641	14,811
Earnings Per Share, Diluted
Income (Loss) from Continuing Operations, Per Diluted Share	$ (0.03)	$ (0.12)	$ (0.04)	$ (0.13)
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share	5.25	0.15	5.65	0.45
Earnings Per Share, Diluted	$ 5.22	$ 0.03	$ 5.61	$ 0.32
Weighted Average Number of Shares Outstanding, Diluted	14,642	14,765	14,641	14,811

Condensed Consolidated Statemen

Condensed Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Details
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 76,368	$ 538	$ 81,934	$ 4,860
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax	1,212	2,227	(1,248)	2,093
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax	260	474	(271)	451
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax	952	1,753	(977)	1,642
Other Comprehensive Income (Loss), Net of Tax	952	1,753	(977)	1,642
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	77,320	2,291	80,957	6,502
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Net Income (Loss) Attributable to Noncontrolling Interest	(103)	117	(158)	161
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest	0	0	0	0
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest	(103)	117	(158)	161
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ 77,423	$ 2,174	$ 81,115	$ 6,341

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands	Total	COMMON STOCK, AMOUNT	Additional Paid-in Capital	AOCI Attributable to Parent	Treasury Stock	Retained Earnings	Parent	Noncontrolling Interest
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2019	$ 459,712	$ 18,625	$ 122,717	$ 1,212	$ (69,724)	$ 386,864	$ 459,694	$ 18
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest	4,733					4,699	4,699	34
Other Comprehensive Income (Loss), Net of Tax	1,642			1,642			1,642	0
Dividends, Common Stock, Cash	3,246					3,246	3,246	0
Sharebased Compensation Effect On Stockholders Equity	1,087		1,087				1,087	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2020	459,324	18,625	123,804	2,854	(74,325)	388,317	459,275	49
Treasury Stock, Value, Acquired, Cost Method	4,601				4,601		4,601	0
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	3						0	3
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2020	459,898	18,625	123,260	1,101	(71,196)	388,102	459,892	6
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest	464					421	421	43
Other Comprehensive Income (Loss), Net of Tax	1,753			1,753			1,753	0
Dividends, Common Stock, Cash	206					206	206	0
Sharebased Compensation Effect On Stockholders Equity	544		544				544	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2020	459,324	18,625	123,804	2,854	(74,325)	388,317	459,275	49
Treasury Stock, Value, Acquired, Cost Method	3,129				3,129		3,129	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2020	469,806	18,625	124,757	4,197	(77,088)	399,273	469,764	42
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest	82,090					82,092	82,092	(2)
Other Comprehensive Income (Loss), Net of Tax	(977)			(977)			(977)	0
Dividends, Common Stock, Cash	3,226					3,226	3,226	0
Sharebased Compensation Effect On Stockholders Equity	935		896		39		935	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2021	548,488	18,625	125,653	3,220	(77,189)	478,139	548,448	40
Treasury Stock, Value, Acquired, Cost Method	140				140		140	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2021	473,789	18,625	125,189	2,268	(77,228)	404,894	473,748	41
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest	76,470					76,471	76,471	(1)
Other Comprehensive Income (Loss), Net of Tax	952			952			952	0
Dividends, Common Stock, Cash	3,226					3,226	3,226	0
Sharebased Compensation Effect On Stockholders Equity	503		464		39		503	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2021	$ 548,488	$ 18,625	$ 125,653	$ 3,220	$ (77,189)	$ 478,139	$ 548,448	$ 40

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Stockholders' Equity - Parenthetical - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Details
Common Stock, Dividends, Per Share, Declared	$ 0.22	$ 0.22	$ 0.22	$ 0.22

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
CASH FLOWS PROVIDED BY (USED BY) OPERATING ACTIVITIES:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 81,934	$ 4,860
Net Cash Provided by (Used in) Operating Activities	53,535	28,247
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	(47,768)	(428)
Adjustments to reconcile net income to net change in cash from
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax	(74,534)	0
Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax	812	0
Deferred Policy Acquisition Costs, Amortization Expense	425	166
Investment Income, Net, Amortization of Discount and Premium	(1,139)	(1,218)
Gain (Loss) on Investments	91	117
Depreciation, Depletion and Amortization, Nonproduction	908	759
Other Noncash Income (Expense)	(17,107)	(2,393)
Increase (Decrease) in Operating Capital
Increase (Decrease) in Insurance Liabilities	37,333	27,057
Increase (Decrease) in Premiums Receivable	15,141	8,253
Increase (Decrease) in Contract with Customer, Asset	1,006	0
Increase (Decrease) in Reinsurance Recoverable	(2,663)	(3,725)
Change in Claim Fund Balances	(1,022)	574
Increase (Decrease) in Other Operating Assets and Liabilities, Net	(3,008)	4,135
Net Cash Provided by (Used in) Investing Activities
Payments for (Proceeds from) Short-term Investments	(1,060)	1,049
Proceeds from (Payments for) Securities Purchased under Agreements to Resell	(139,647)	5,740
Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment	3,494	0
Proceeds from Sale of Debt Securities, Available-for-sale	10,366	36,413
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	44,520	55,936
Payments to Acquire Debt Securities, Available-for-sale	8,343	96,353
Cash Divested from Deconsolidation	4,878	0
Payments to Acquire Businesses, Net of Cash Acquired	0	13,707
Payments to Acquire Other Investments	2,500	1,250
Other investing activities	1,870	3,372
Net Cash Provided by (Used in) Investing Activities	(97,798)	(17,642)
Net Cash Provided by (Used in) Financing Activities
Payments for Repurchase of Common Stock	140	4,489
Net Change Annuities and Investment Certificates	(112)	(326)
Payments of Ordinary Dividends, Common Stock	3,221	6,215
Proceeds from (Payments for) Other Financing Activities	(32)	(3)
Net Cash Provided by (Used in) Financing Activities	(3,505)	(11,033)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Beginning Balance	74,793	24,631
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Ending Balance	27,025	24,203
Noncash or Part Noncash Divestiture, Amount of Consideration Received	$ 78,779	$ 0

Organization, Consolidation, Ba

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies	Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies (A) Business and Organization (B) Basis of Presentation The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles ("GAAP") for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. IHC’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements. During the second quarter of 2021, the Board of Directors committed to various plans for the disposal of several business operations (see Note 2). Each plan represents a strategic shift that will have a major effect on the Company’s operations and financial results and as such, they each qualify for reporting as discontinued operations in the second quarter 2021. The assets, liabilities, and related income and expenses associated with each disposal group are presented as discontinued operations in the accompanying condensed consolidated financial statements and Notes thereto for all periods presented. In March 2020, the World Health Organization declared the outbreak of COVID-19 a global health pandemic and the United States declared a national health emergency. COVID-19 has led to largescale disruption in the global economy, market instability and widespread unemployment in the United States. The COVID-19 outbreak continues to be a fluid situation and as it evolves, the duration of COVID-19 and its potential effects on our business cannot be certain. Regulatory mandates have affected, and we anticipate will continue to impact, the insurance industry. We currently cannot predict if there will be a material impact to our business, results of operations or financial condition in future reporting periods. Consequently, future changes in market conditions may impact estimates used in the preparation of our financial statements associated with evaluations of goodwill and other intangible assets for impairment, estimates associated with the determination of valuation allowances related to net operating loss carryforwards, and estimates of certain losses under insurance contracts. These estimates may all be subject to substantial adjustments in future periods. In addition, volatile market conditions may result in declines in the fair value of our investment portfolio and possible impairments of certain securities. In the opinion of management, all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been included. The condensed consolidated results of operations for the three months and six months ended June 30, 2021 are not necessarily indicative of the results to be anticipated for the entire year. (C) Reclassifications Certain amounts in prior year’s condensed consolidated financial statements and Notes thereto have been reclassified to conform to the 2021 presentation, primarily for the effects of discontinued operations. (D) Recent Accounting Pronouncements Recently Adopted Accounting Standards In December 2019, the Financial Accounting Standard Board (“FASB”) issued guidance to simplify the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes, the requirement to allocate current and deferred tax expense to legal entities not subject to tax in its separate financial statements, enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. Recently Issued Accounting Standards Not Yet Adopted In August 2018, the FASB issued guidance to improve existing measurements, presentation and disclosure requirements for long-duration contracts issued by insurance entities. The amendments in this guidance requires an entity to (1) review and update assumptions used to measure cash flows at least annually as well as update the discount rate assumption at each reporting date; (2) measure market risk benefits associated with deposit contracts at fair value; (3) disclose liability rollforwards and information about significant inputs, judgements assumptions, and methods used in measurement. Additionally, it simplifies the amortization of deferred acquisition costs and other balances on a constant level basis over the expected term of the related contracts. In 2019, the FASB delayed the original effective dates. For smaller reporting companies, the amendments in this guidance are now effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Upon adoption, the amendments in this guidance should be applied to contracts in-force as of the beginning of the earliest period presented with a cumulative adjustment to beginning retained earnings. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. In June 2016, the FASB issued guidance requiring financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. An allowance for credit losses will be deducted from the amortized cost basis to present the net carrying value at the amount expected to be collected with changes in the allowance recorded in earnings. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than the currently applied U.S. GAAP method of taking a permanent impairment of the security, which would be limited to the amount by which fair value is below the amortized cost. Certain existing requirements used to evaluate credit losses have been removed. In 2019, the FASB provided transition relief by providing entities with an option to irrevocably elect the fair value option on an instrument-by-instrument basis for eligible instruments upon adoption and delayed the original effective dates. For smaller reporting companies, the amendments in this guidance are now effective for fiscal years beginning after December 15, 2022, including interim periods within those years. Early adoption is permitted. The amendments in this guidance should be applied through a cumulative effect adjustment to retained earnings upon adoption as of the beginning of the first reporting period in which the guidance is effective. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements.

Disposal Groups, Including Disc

Disposal Groups, Including Discontinued Operations, Disclosure	6 Months Ended
	Jun. 30, 2021
Notes
Disposal Groups, Including Discontinued Operations, Disclosure	Note 2. Discontinued Operations (A) Sale of Standard Security Life On April 14, 2021, IHC and its wholly owned subsidiary, Independence Capital Corp. (“ICC”), entered into a Stock Purchase Agreement (the “SSL Purchase Agreement”) with Reliance Standard Life Insurance Company (“Reliance Standard”) to sell all of the issued and outstanding capital stock of Standard Security Life, a wholly owned subsidiary of ICC, for an aggregate purchase price of $180,000,000 in cash. In addition, at closing, the Company will receive a dividend from Standard Security Life equal to the excess of aggregate statutory capital and surplus over $53,000,000 as of the closing date. Standard Security Life had statutory capital and surplus of $82,091,000 at June 30, 2021. The closing of the transaction, the closing dividend and certain other items are subject to customary closing conditions including applicable regulatory approvals, one of which is the approval of the New York State Department of Financial Services. Standard Security Life currently cedes a portion of its New York short-term disability (“DBL”) and paid family leave rider (“PFL”) business to Independence American Insurance Company. We filed notice to cancel this reinsurance contract in accordance with the terms of the SSL Purchase Agreement. Under the terms of the SSL Purchase Agreement, the sale transaction will include all of Standard Security Life’s DBL and PFL business (including the DBL and PFL business previously ceded to Independence American Insurance Company) and will exclude other lines of business which will be reinsured prior to the closing. The DBL and PFL business being sold was part of the Company’s Group disability, life, DBL and PFL segment. The aforementioned transaction, consisting of the sale of Standard Security Life, the closing dividend and other closing conditions, is collectively referred to as the “SSL Sale” transaction or disposal group. DBL and PFL are major product lines for the Company. The sale of Standard Security Life and resulting exit from DBL and PFL business represents a strategic shift that will have a major effect on the Company’s operations and financial results. The SSL Sale transaction qualified for reporting as discontinued operations in the second quarter of 2021 upon the Board of Director’s commitment to a plan for its disposal in April 2021, and the subsequent execution of the SSL Purchase Agreement. Provided that all regulatory approvals and other closing conditions are met, the Company expects to complete the SSL Sale transaction by the end of 2021. On July 29, 2021, the SSL Purchase Agreement was amended and restated to: (i) include in the disposal group, the business lines that were previously excluded from the transaction; (ii) remove the reinsurance requirement for the previously excluded business lines; and (iii) increase the target statutory capital and surplus to $57,000,000. As a result of this change in the disposal plan, the Company will include the assets, liabilities and results of operations for those business lines affected in discontinued operations for all periods presented, beginning in the third quarter of 2021. Aside from customary transition services, there will be no continuing involvement with Standard Security Life after its disposal. (B) Sale of Pet Division and Independence American Insurance Company (“Pets Sale”) On May 17, 2021, IHC and certain subsidiaries entered into agreements to sell a 70% controlling interest in its pet division, including all of the issued and outstanding capital stock of Independence American Insurance Company to a subsidiary of Iguana Capital, Inc. (“Iguana Capital”), an investment company specifically formed to facilitate this transaction as follows: (i) (ii) (iii) Both agreements are subject to customary closing conditions. The closing of the IAHC Purchase Agreement however is also subject to certain regulatory approvals, one of which is the approval of the Delaware Insurance Department. For this reason, the transaction was structured as two agreements such that the sale of PetPartners occurred on June 30, 2021, and the closing of the transactions contemplated in the IAHC Purchase Agreement will follow at a later date upon receipt of applicable regulatory approvals. Provided that all regulatory approvals and other closing conditions are met, the Company expects to complete the IAHC sale transaction by the end of 2021. Under the terms of the IAHC Purchase Agreement, the transaction includes the sale of all Independence American Insurance Company’s pet business and excludes other business lines. These excluded business lines will be retained by the Company through a reinsurance agreement with Madison National Life prior to closing. The reinsurance agreement will remain in effect until the underlying business is either transferred to Madison National Life or the business runs out. The aforementioned transaction, consisting of the sale of PetPartners, IAHC and Independence American Insurance Company, and other closing conditions, is collectively referred to as the “Pets Sale” transaction or disposal group. The pet business being sold was part of the Company’s Specialty Health segment. Because the pet business is a major product line for the Company, and the Company will no longer actively engage in the sales and marketing of pet insurance, the Pets Sale transaction represents a strategic shift that will have a major effect on the Company’s operations and financial results. The Pets Sale transaction qualified for reporting as discontinued operations in the second quarter of 2021 as a result of the Board of Directors’ commitment to a plan for the disposal of a controlling interest in its pet business in May 2021, and the execution of both the PPI Purchase Agreement and the IAHC Purchase Agreement on May 17, 2021. On June 30, 2021, the Company completed the sale of its majority interest in PetPartners and, as a result, the Company ceased to have a controlling financial interest in PetPartners. Upon closing, the Company received proceeds of $78,779,000 (consisting of the purchase price and certain initial working capital adjustments), recognized an initial equity investment in Iguana Capital valued at $33,762,000, and recorded a $62,693,000 gain on the disposal, net of transaction costs and income taxes. Transaction costs consisting of transaction bonuses, legal expenses and financial advisor expenses amounted to an aggregate of $6,070,000. The PPI Purchase Agreement includes a waiver and consent to offer The American Kennel Club (“AKC”), PetPartners’ minority shareholder, until December 31, 2021, the right to sell their shares at the same price and terms as in the PPI Purchase Agreement. In the event AKC desires to sell such its shares, Iguana Capital and SBH will equally finance the cash payment to AKC. In connection with the PPI Sale transaction, the Company recorded a $6,800,000 contingent liability (the maximum amount required) based on its belief that AKC will exercise this right. If for any reason the IAHC Purchase Agreement is terminated, then at the option of either SBH or an affiliate of Iguana Capital, IAHC may reacquire the Company’s interest in PetPartners (the “PPI Put/Call Option”). The value of the PPI Put/Call Option was deemed to be negligible due to the structure of the put and call features, the short time horizon and the Company’s belief that there is a low probability that the deal would be terminated. The proceeds received from the sale of PetPartners were deposited into an escrow account owned by SBH and treated as a security deposit. The funds will be released from escrow upon either the consummation of the IAHC sale transaction or upon the exercise of the PPI Put/Call Option. At June 30, 2021, the security deposit is presented as funds held in escrow on the Condensed Consolidated Balance Sheet. Continuing involvement with the Pets Sale disposal group will consist of customary transition services, the reinsurance of retained business lines, the PPI Put/Call Option, and the equity investment in Iguana Capital. The following is a reconciliation, by disposal group, of the carrying amounts of major classes of assets and liabilities included in discontinued operations on the Condensed Consolidated Balance Sheets for the periods indicated (in thousands): June 30, 2021 SSL Sale Pets Sale Total Major classes of assets: Investments and cash $ 164,346 $ 144,688 $ 309,034 Goodwill - 41,716 41,716 Other assets 30,020 35,392 65,412 Assets attributable to discontinued operations $ 194,366 $ 221,796 $ 416,162 Major classes of liabilities: Policy benefits and claims $ 56,987 $ 12,743 $ 69,730 Unearned premiums 26,778 6,080 32,858 Other liabilities 12,500 5,092 17,592 Liabilities attributable to discontinued operations $ 96,265 $ 23,915 $ 120,180 December 31, 2020 SSL Sale Pets Sale Total Major classes of assets included in discontinued operations: Investments and cash $ 114,916 $ 149,844 $ 264,760 Goodwill - 62,414 62,414 Other assets 18,787 29,730 48,517 Assets attributable to discontinued operations $ 133,703 $ 241,988 $ 375,691 Major classes of liabilities included in discontinued operations: Policy benefits and claims $ 34,500 $ 11,775 $ 46,275 Unearned premiums 5,208 5,629 10,837 Other liabilities 9,316 9,511 18,827 Liabilities attributable to discontinued operations $ 49,024 $ 26,915 $ 75,939 The following is a reconciliation, by disposal group, of the major line items constituting the pretax profit of discontinued operations to the income from discontinued operations, net of tax, as shown on the Condensed Consolidated Statements of Income for the periods indicated (in thousands): For the Three Months Ended June 30, 2021 SSL Sale Pets Sale Total Revenues $ 50,342 $ 33,080 $ 83,422 Expenses: Insurance benefits, claims and reserves 24,341 18,442 42,783 Selling, general and administrative expenses 7,394 14,592 21,986 Pretax income of discontinued operations during phase-out 18,607 46 18,653 Pretax provision for loss on disposal (402) (410) (812) Pretax gain on disposal of discontinued operations - 74,534 74,534 Total pretax income from discontinued operations 18,205 74,170 92,375 Income tax expense on discontinued operations 3,836 11,734 15,570 Income from discontinued operations, net of tax $ 14,369 $ 62,436 $ 76,805 For the Three Months Ended June 30, 2020 SSL Sale Pets Sale Total Revenues $ 30,442 $ 20,407 $ 50,849 Expenses: Insurance benefits, claims and reserves 22,152 11,098 33,250 Selling, general and administrative expenses 6,150 7,855 14,005 Pretax income of discontinued operations during phase-out 2,140 1,454 3,594 Pretax provision for loss on disposal - - - Pretax gain on disposal of discontinued operations - - - Total pretax income from discontinued operations 2,140 1,454 3,594 Income tax expense on discontinued operations 822 442 1,264 Income from discontinued operations, net of tax $ 1,318 $ 1,012 $ 2,330 For the Six Months Ended June 30, 2021 SSL Sale Pets Sale Total Revenues $ 93,738 $ 61,999 $ 155,737 Expenses: Insurance benefits, claims and reserves 53,865 34,374 88,239 Selling, general and administrative expenses 14,850 26,796 41,646 Pretax income of discontinued operations during phase-out 25,023 829 25,852 Pretax provision for loss on disposal (402) (410) (812) Pretax gain on disposal of discontinued operations - 74,534 74,534 Total pretax income from discontinued operations 24,621 74,953 99,574 Income tax expense on discontinued operations 5,151 11,875 17,026 Income from discontinued operations, net of tax $ 19,470 $ 63,078 $ 82,548 For the Six Months Ended June 30, 2020 SSL Sale Pets Sale Total Revenue $ 59,943 $ 37,838 $ 97,781 Expenses: Insurance benefits, claims and reserves 40,560 20,459 61,019 Selling, general and administrative expenses 13,004 14,515 27,519 Pretax income of discontinued operations during phase-out 6,379 2,864 9,243 Pretax provision for loss on disposal - - - Pretax gain on disposal of discontinued operations - - - Total pretax income from discontinued operations 6,379 2,864 9,243 Income tax expense on discontinued operations 1,689 741 2,430 Income from discontinued operations, net of tax $ 4,690 $ 2,123 $ 6,813 The assets and liabilities in discontinued operations are measured at the lower of their carry value or fair value less cost to sell. During the three months and six months ended June 30, 2021, it was not necessary to write-down any assets or liabilities attributable to the disposal groups in discontinued operations to fair value, less costs to sell. The Company expects to recognize gains from the sales of these disposal groups, therefore, any costs to sell the disposal groups, primarily legal expenses, incurred prior to the actual disposal of the discontinued operation, are expensed when incurred and presented in pretax provision for loss on disposal in the tables above. Pretax income (loss) from discontinued operations during phase-out attributable to IHC was $18,653,000 and $25,852,000 for the three and six months ended June 30, 2021, respectively, and was $3,594,000 and $9,243,000 for the three and six months ended June 30, 2020, respectively. Total cash flows from operating activities of discontinued operations were $45,917,000 and $26,813,000 for the six months ended June 30, 2021 and 2020, respectively. Total cash flows from investing activities of discontinued operations were $(88,501,000) and $(29,753,000) for the six months ended June 30, 2021 and 2020, respectively. On a consolidated basis, the Company recorded $15,570,000 and $1,264,000 of income taxes related to pretax income from discontinued operations for the three months ended June 30, 2021 and 2020, respectively, and $17,026,000 and $2,430,000 for the six months ended June 30, 2021 and 2020, respectively. In 2021, these amounts include $11,841,000 of income taxes related to the pretax gain on disposal of discontinued operations. In connection with the sale of PetPartners, AMIC decreased its valuation allowance on existing deferred tax assets by $8,281,000 and utilized approximately $46,116,000 of its outstanding Federal net operating loss carryforwards (See Note 11). Differences between the Federal statutory income tax rate on discontinued operations and the Company’s effective income tax rate on pretax income from discontinued operations are primarily the result of AMIC’s decrease in its valuation allowance, state and local income taxes, nondeductible goodwill and other expenses.

Earnings Per Share _Text Block_

Earnings Per Share [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Earnings Per Share	Note 3. Income Per Common Share Diluted income per share was computed using the treasury stock method. As a result of losses from continuing operations for the three months and six months ended June 30, 2021 and 2020, such shares were deemed anti-dilutive. The following is a reconciliation of income available to common shareholders used to calculate income per share for the periods indicated (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Income from continuing operations attributable to IHC $ (436) $ (1,835) $ (612) $ (1,987) Income from discontinued operations attributable to IHC $ 76,907 $ 2,256 $ 82,704 $ 6,686 Net income attributable to IHC $ 76,471 $ 421 $ 82,092 $ 4,699

Cash and Cash Equivalents Discl

Cash and Cash Equivalents Disclosure	6 Months Ended
	Jun. 30, 2021
Notes
Cash and Cash Equivalents Disclosure	Note 4. Cash, Cash Equivalents and Restricted Cash June 30, 2021 2020 Cash and cash equivalents $ 22,834 $ 11,655 Restricted cash in other assets 418 985 Cash, cash equivalents and restricted cash in discontinued operations 3,773 11,563 Total cash, cash equivalents and restricted cash including discontinued operations $ 27,025 $ 24,203 Restricted cash includes insurance premiums collected from insureds that are pending remittance to insurance carriers and/or payment of insurance claims and commissions to third party administrators. These amounts are required to be set aside by contractual agreements with the insurance carriers and are included in other assets on the Condensed Consolidated Balance Sheets.

Investments in Debt and Marketa

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure	Note 5. Investment Securities The cost (amortized cost with respect to certain fixed maturities), gross unrealized gains, gross unrealized losses and fair value of fixed maturities available-for-sale are as follows for the periods indicated (in thousands): June 30, 2021 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 75,245 $ 1,583 $ (779) $ 76,049 CMOs – residential (1) 3,071 118 (5) 3,184 U.S. Government obligations 23,029 273 - 23,302 Agency MBS - residential (2) 35 - (4) 31 GSEs (3) 2,969 - (84) 2,885 States and political subdivisions 74,086 1,261 (384) 74,963 Foreign government obligations 3,144 151 - 3,295 Total fixed maturities $ 181,579 $ 3,386 $ (1,256) $ 183,709 December 31, 2020 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 91,802 $ 2,174 $ (1,302) $ 92,674 CMOs – residential (1) 3,439 146 (2) 3,583 U.S. Government obligations 23,397 414 - 23,811 Agency MBS - residential (2) 39 - (5) 34 GSEs (3) 3,055 - (81) 2,974 States and political subdivisions 82,910 1,768 (452) 84,226 Foreign government obligations 3,211 206 - 3,417 Total fixed maturities $ 207,853 $ 4,708 $ (1,842) $ 210,719 (1) (2) (3) The amortized cost and fair value of fixed maturities available-for-sale at June 30, 2021, by contractual maturity, are shown below (in thousands). Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. AMORTIZED FAIR COST VALUE Due in one year or less $ 36,481 $ 36,938 Due after one year through five years 87,377 89,128 Due after five years through ten years 20,124 20,292 Due after ten years 31,522 31,252 Fixed maturities with no single maturity date 6,075 6,099 $ 181,579 $ 183,709 The following tables summarize, for all fixed maturities available-for-sale in an unrealized loss position, the aggregate fair value and gross unrealized loss by length of time those securities that have continuously been in an unrealized loss position for the periods indicated (in thousands): June 30, 2021 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 19,962 $ 740 $ 4,503 $ 39 $ 24,465 $ 779 CMOs-residential 707 5 - - 707 5 Agency MBS - residential 31 4 - - 31 4 GSEs - 2,886 84 2,886 84 States and political subdivisions 10,319 76 8,813 308 19,132 384 Fixed maturities in an unrealized loss position $ 31,019 $ 825 $ 16,202 $ 431 $ 47,221 $ 1,256 Number of fixed maturities in an unrealized loss position 9 14 23 December 31, 2020 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 23,591 $ 458 $ 8,845 $ 844 $ 32,436 $ 1,302 CMOs-residential 748 2 - - 748 2 Agency MBS - residential 34 5 - - 34 5 GSEs - - 2,974 81 2,974 81 States and political subdivisions 16,983 150 6,108 302 23,091 452 Fixed maturities in an unrealized loss position $ 41,356 $ 615 $ 17,927 $ 1,227 $ 59,283 $ 1,842 Number of fixed maturities in an unrealized loss position 20 13 33 Substantially all of the unrealized losses on fixed maturities available-for-sale at June 30, 2021 and December 31, 2020 relate to investment grade securities. Management does not intend to sell, and it is likely that management will not be required to sell these securities prior to their anticipated recovery. The unrealized losses on the Company's fixed maturity securities are related to general market changes in interest rates, and/or the levels of credit spreads largely due to current market conditions relating to the COVID-19 pandemic rather than specific concerns with the issuer's ability to pay interest and repay principal. We have evaluated each corporate security’s credit rating as well as industry risk factors associated with the securities. The fair value of these securities is expected to recover as they approach maturity and therefore the Company does not consider these investments to be other-than-temporarily impaired at June 30, 2021. Net investment gains are as follows for periods indicated (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Realized gains (losses): Fixed maturities available-for-sale $ (126) $ 50 $ 46 $ 284 Equity securities - - 292 - Total realized gains (losses) on debt and equity securities (126) 50 338 284 Unrealized gains (losses) on equity securities - 214 (247) (184) Gains (losses) on debt and equity securities (126) 264 91 100 Gains (losses) on other investments - 10 - 17 Net investment gains $ (126) $ 274 $ 91 $ 117 For the three months and six months ended June 30, 2021, the Company realized gross gains of $61,000 and $254,000, respectively, and gross losses of $187,000 and $206,000, respectively, from sales, maturities and prepayments of fixed maturities available-for-sale. For the three months and six months ended June 30, 2020, the Company realized gross gains of $97,000 and $346,000, respectively, and gross losses of $47,000 and $62,000, respectively, from sales, maturities and prepayments of fixed maturities available-for-sale. Other-Than-Temporary Impairment Evaluations We recognize other-than-temporary impairment losses in earnings in the period that we determine: 1) we intend to sell the security; 2) it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis; or 3) the security has a credit loss. Any non-credit portion of the other-than-temporary impairment loss is recognized in other comprehensive income (loss). See Note 1G(v) to the Consolidated Financial Statements in the 2020 Annual Report on Form 10-K for further discussion of the factors considered by management in its regular review to identify and recognize other-than-temporary impairments on fixed maturities available-for-sale. The Company did not recognize any other-than-temporary impairments on available-for-sale securities in the first six months of 2021 or 2020.

Fair Value Disclosures _Text Bl

Fair Value Disclosures [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Fair Value Disclosures	Note 6. Fair Value Disclosures For all financial and non-financial assets and liabilities accounted for at fair value on a recurring basis, the Company utilizes valuation techniques based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market expectations. These two types of inputs create the following fair value hierarchy: Level 1 Level 2 Level 3 The following section describes the valuation methodologies we use to measure different assets at fair value. Fixed maturities available-for-sale: Fixed maturities available-for-sale included in Level 2 are comprised of our portfolio of government securities, agency mortgage-backed securities, corporate fixed income securities, foreign government obligations, collateralized mortgage obligations, municipals and GSEs that were priced with observable market inputs. Level 3 debt securities consist of municipal tax credit strips. The valuation method used to determine the fair value of municipal tax credit strips is the present value of the remaining future tax credits (at the original issue discount rate) as presented in the redemption tables in the Municipal Prospectuses. This original issue discount is accreted into income on a constant yield basis over the term of the debt instrument. Further, we retain independent pricing vendors to assist in valuing certain instruments. Equity securities: The following tables present our financial assets measured at fair value on a recurring basis for the periods indicated (in thousands): June 30, 2021 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 76,049 $ - $ 76,049 CMOs - residential - 3,184 - 3,184 US Government obligations - 23,302 - 23,302 Agency MBS - residential - 31 - 31 GSEs - 2,885 - 2,885 States and political subdivisions - 73,949 1,014 74,963 Foreign government obligations - 3,295 - 3,295 Total fixed maturities - 182,695 1,014 183,709 Total Financial Assets $ - $ 182,695 $ 1,014 $ 183,709 December 31, 2020 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 92,674 $ - $ 92,674 CMOs - residential - 3,583 - 3,583 US Government obligations - 23,811 - 23,811 Agency MBS - residential - 34 - 34 GSEs - 2,974 - 2,974 States and political subdivisions - 83,130 1,096 84,226 Foreign government obligations - 3,417 - 3,417 Total fixed maturities - 209,623 1,096 210,719 Equity securities: Common stocks 1,753 - - 1,753 Total equity securities 1,753 - - 1,753 Total Financial Assets $ 1,753 $ 209,623 $ 1,096 $ 212,472 The following table presents the changes in fair value of our Level 3 financial assets for the periods indicated (in thousands): Three Months Ended June 30, 2021 2020 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning b alance $ 1,055 $ 1,055 $ 1,214 $ 1,214 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (4) (4) (5) (5) Repayments and amortization of fixed maturities (37) (37) (34) (34) Balance at end of period $ 1,014 $ 1,014 $ 1,175 $ 1,175 Six Months Ended June 30, 2021 2020 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning b alance $ 1,096 $ 1,096 $ 1,251 $ 1,251 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (8) (8) (9) (9) Repayments and amortization of fixed maturities (74) (74) (67) (67) Balance at end of period $ 1,014 $ 1,014 $ 1,175 $ 1,175 Included in unrealized gains (losses) on available-for-sale securities, pre-tax, on the Condensed Consolidated Statement of Comprehensive Income for the three months and six months ended June 30, 2021 are $(4,000) and $(8,000) of unrealized gains (losses) attributable to the change in unrealized gains (losses) related to Level 3 securities held at June 30, 2021. The following table provides carrying values, fair values and classification in the fair value hierarchy of the Company’s financial instruments, that are not carried at fair value but are subject to fair value disclosure requirements, for the periods indicated (in thousands): June 30, 2021 December 31, 2020 Level 1 Level 2 Level 1 Level 2 Fair Fair Carrying Fair Fair Carrying Value Value Value Value Value Value FINANCIAL ASSETS: Short-term investments $ 1,550 $ - $ 1,550 $ 1,568 $ - $ 1,568 Securities purchased under agreements to resell 70,323 - 70,323 33,038 - 33,038 FINANCIAL LIABILITIES: Funds on deposit $ - $ 142,155 $ 142,155 $ - $ 141,376 $ 141,376 Other policyholders’ funds - 11,988 11,988 - 12,001 12,001 The following methods and assumptions were used to estimate the fair value of the financial instruments that are not carried at fair value in the Condensed Consolidated Financial Statements: Securities purchased under agreements to resell Securities purchased under agreements to resell are carried at the amounts at which the securities will be subsequently resold, which approximates fair value. Short-term Investments Investments with original maturities of 91 days to one year are considered short-term investments and are carried at cost, which approximates fair value. Funds on Deposit The Company has two types of funds on deposit. The first type is credited with a current market interest rate, resulting in a fair value which approximates the carrying amount. The second type carries fixed interest rates which are higher than current market interest rates. The fair value of these deposits was estimated by discounting the payments using current market interest rates. The Company's universal life policies are also credited with current market interest rates, resulting in a fair value which approximates the carrying amount. Both types of funds on deposit are included in Level 2 of the fair value hierarchy. Other Policyholders’ Funds Other policyholders’ funds are primarily credited with current market interest rates resulting in a fair value which approximates the carrying amount.

Investments in and Advances to

Investments in and Advances to Affiliates, Schedule of Investments [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Investments in and Advances to Affiliates, Schedule of Investments	Note 7. Other Investments, Including Variable Interest Entities Equity Method Investments Equity income (loss) from equity method investments for the three months and six months ended June 30, 2021 was $4,000 and $64,000 respectively; and was $(356,000) and $(28,000) for the three months and six months ended June 30, 2020, respectively. Variable Interest Entities The Company has a minority interest in certain limited partnerships that we have determined to be Variable Interest Entities (“VIEs”). The aforementioned VIEs are not required to be consolidated in the Company’s condensed consolidated financial statements as we are not the primary beneficiary since we do not have the power to direct the activities that most significantly impact the VIEs’ economic performance. The Company will periodically reassess whether we are the primary beneficiary in any of these investments. The reassessment process will consider whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. Our maximum loss exposure is limited to our combined $2,022,000 carrying value in these equity investments which is included in other investments in the Condensed Consolidated Balance Sheet as of June 30, 2021. Related Party Transactions At June 30, 2021 and December 31, 2020, the Company’s Condensed Consolidated Balance Sheets include $94,000 and $163,000, respectively, of administrative fees and other expenses payable to Ebix Health Exchange Holdings, LLC (“Ebix Health Exchange”), which are included in other assets and accounts payable, accruals and other liabilities, respectively. The Company’s Condensed Consolidated Statements of Income include administrative fee expenses to Ebix Health Exchange, which are included in selling, general and administrative expenses, of $361,000 and $762,000, respectively, for the three months and six months ended June 30, 2021; and include $423,000 and $899,000, respectively, for the same periods in 2020.

Business Combination Disclosure

Business Combination Disclosure	6 Months Ended
	Jun. 30, 2021
Notes
Business Combination Disclosure	Note 8. Acquisitions The Abacus Group, LLC . On January 1, 2020 (the "Abacus Acquisition Date"), the Company acquired the remaining 56% membership units of The Abacus Group, LLC, (“Abacus”) for a purchase price of $2,599,000, Abacus is an agency group that writes worksite business for Madison National Life and other carriers and receives commissions and other fees. The Company acquired Abacus to further the Company’s position in the worksite marketplace. The Company accounted for its prior ownership interest using the equity method. Immediately preceding the transaction, the Company determined the fair value of its equity interest to be $1,838,000 using a market approach and, as a result, recorded a loss of $163,000, which is included in other income on the Condensed Consolidated Statement of Income. Upon the acquisition, the Company consolidated the assets and liabilities of Abacus. The following table presents the identifiable assets acquired and liabilities assumed in the acquisition of Abacus on the Abacus Acquisition Date based on their respective fair values (in thousands): Other assets $ 350 Total identifiable assets 350 Other liabilities 575 Total liabilities 575 Net identifiable assets (liabilities) acquired $ (225) In connection with the acquisition, the Company recorded $4,662,000 of goodwill of which $2,725,000 is deductible for income tax purposes. Goodwill represents the synergies with our insurance carriers. Abacus has an existing distribution network and offers increased distribution sources for IHC carriers’ existing products and developing products through its enrollment platform designed specifically for producers in the worksite marketplace. Goodwill was calculated as the sum of (i) the acquisition date fair value of total cash consideration transferred of $2,599,000, (ii) the aggregate acquisition-date fair value of equity interests immediately before the acquisition of $1,838,000, and (iii) the net identifiable liabilities of $225,000 that were assumed. The enterprise value of Abacus was determined by a market approach net of any control premium. Acquisition-related costs, primarily legal and consulting fees, were not material and are included in selling, general and administrative expenses in the Condensed Consolidated Statement of Income. Revenue and net income from Abacus for the period from the Abacus Acquisition Date to June 30, 2020, is not material as most of their agency fee income is derived from Madison National Life and is now eliminated in consolidation. The amount of fee income earned from other carriers in 2020 is not material and will reduce over time as the business either runs-off or is transitioned to Madison National Life. Pro forma adjustments to present the Company’s consolidated revenues and net income as if the acquisition date was January 1, 2019 are not material and accordingly are omitted. Torchlight Technology Group LLC. On April 15, 2020 (the "Torchlight Acquisition Date"), the Company acquired the remaining 77% membership units of Torchlight Technology Group LLC, (“Torchlight”) for a purchase price of $11,443,000 in cash and other consideration valued at $185,000. In accordance with the purchase and sale agreement, the Company will also make future incentive payments to the former owners based on the future market appreciation of IHC. These payments will be accounted for as compensation for post-combination services. The Company purchased Torchlight for its marketing technology (“MarTech”), artificial data intelligence, and consumer lead generation capabilities. In an effort to further expand our InsureTech division (comprised of Torchlight, our call centers, field and career agents, and web domains), the Company wants to be able to internally develop and deliver lead traffic opportunities in an affordable and controlled environment. The Company accounted for its prior ownership interest using the equity method. Immediately preceding the transaction, the Company determined the fair value of its equity interest to be $3,432,000 using the income approach and, as a result, recorded a gain of $519,000, which is included in other income on the Condensed Consolidated Statement of Income. Upon the acquisition, the Company consolidated the assets and liabilities of Torchlight. The following table presents the identifiable assets acquired and liabilities assumed in the acquisition of Torchlight on the Torchlight Acquisition Date based on their respective fair values (in thousands): Cash $ 333 Intangible assets 2,700 Other assets 2,132 Total identifiable assets 5,165 Other liabilities 1,227 Total liabilities 1,227 Net identifiable assets acquired $ 3,938 In connection with the acquisition, the Company recorded $11,122,000 of goodwill, of which $7,976,000 is deductible for income tax purposes, and $2,700,000 of intangible assets. In 2021, a portion of this goodwill was allocated to the Pets Sale disposal group presented in discontinued operations. Goodwill represents the synergies with our agencies. With a significant dependence on consumer and small business opportunities, our agencies require a consistent and predictable flow of lead traffic, and as a result, have meaningful synergies with the functions and deliverables that are developed at Torchlight. Before the acquisition of Torchlight, our agency was fully dependent on market traffic, which was both unpredictable in price and availability. Such restrictions would not allow for coordinated or scheduled growth. Goodwill was calculated as the sum of (i) the acquisition date fair value of total aggregate consideration transferred of $11,628,000; and (ii) the aggregate acquisition-date fair value of equity interests immediately before the acquisition of $3,432,000; over (iii) the net identifiable assets of $3,938,000 that were acquired. The enterprise value of Torchlight was determined by an independent appraisal using a discounted cash flow model. Acquisition-related costs, primarily legal and consulting fees, were not material and are included in selling, general and administrative expenses in the Condensed Consolidated Statement of Income. Revenue and net loss from Torchlight for the period from the Torchlight Acquisition Date to June 30, 2020 is $1,828,000 and $(564,000), respectively. The net loss is primarily related to the integration of Torchlight with the Company’s other operations. Pro forma adjustments to present the Company’s consolidated revenues and net income as if the acquisition date was January 1, 2019 are not material and accordingly are omitted.

Goodwill and Intangible Assets

Goodwill and Intangible Assets Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Goodwill and Intangible Assets Disclosure	Note 9. Goodwill and Other Intangible Assets The carrying amount of goodwill is $12,486,000 at June 30, 2021 and December 31, 2020, of which $8,263,000 is attributable to the Specialty Health Segment at both June 30, 2021 and December 31, 2020, and $4,223,000 is attributable to the Group disability and life segment for the same periods. The Company has net other intangible assets of $3,667,000 and $4,008,000 at June 30, 2021 and December 31, 2020, respectively, which are included in other assets in the Condensed Consolidated Balance Sheets. These intangible assets consist of: (i) finite-lived intangible assets, principally the fair value of acquired agent and broker relationships, which are subject to amortization; and (ii) indefinite-lived intangible assets which consist of the estimated fair value of insurance licenses that are not subject to amortization. The gross carrying amounts of these other intangible assets are as follows for the periods indicated (in thousands): June 30, 2021 December 31, 2020 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Finite-lived Intangible Assets: Agent and broker relationships $ 6,583 $ 4,599 $ 7,583 $ 5,385 Software systems 1,500 294 1,500 167 Total finite-lived $ 8,083 $ 4,893 $ 9,083 $ 5,552 June 30, December 31, 2021 2020 Indefinite-lived Intangible Assets: Insurance licenses $ 477 $ 477 Total indefinite-lived $ 477 $ 477

Revenue from Contract with Cust

Revenue from Contract with Customer	6 Months Ended
	Jun. 30, 2021
Notes
Revenue from Contract with Customer	Note 10. Fee Income Substantially all of the fee income recorded by the IHC Agencies and lead generation company relate to our Specialty Health segment. The following table presents fee income disaggregated by type for the periods indicated (in thousands). Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Commissions $ 1,416 1,932 4,297 $ 3,672 Administrative Fees 80 581 177 1,069 Marketing Fees 254 292 559 643 Enrollment Platform Fees 529 455 1,029 973 Lead and Referral Fees 2,633 588 4,945 854 Payment Plan, Application and Other Fees 32 59 72 130 Total Fee Income $ 4,944 3,907 11,079 $ 7,341 Commission Revenues Commission revenues result from the sales of certain policies by the IHC Agencies on behalf of multiple unaffiliated insurance carriers. Increased sales of products to these unaffiliated insurance carriers began in 2020 as a result of new contracts with the carriers and increased distribution channels. These policies primarily consist of senior products, such as Medicare Advantage, Medicare Part D prescription drug plans and Medicare Supplement plans, as well as Affordable Care Act (“ACA”) plans. A significant portion of our commission revenues are recorded at a point in time upon the issuance of a policy by the unaffiliated insurance carrier based on expected constrained lifetime value (“LTV”). Constrained LTV represents expected commissions to be received over the lifetime of the policies sold. The Company analyzes various factors, such as commission rates, carrier mix, contract amendments and terminations, estimated average plan durations, cancellations and non-renewals, to estimate the LTV. Constraints are applied to help ensure that the total estimated lifetime commissions expected to be collected are recognized as revenue only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. We evaluate the appropriateness of our constraints on a quarterly basis and update the LTV assumptions if we observe evidence that suggests a change in the underlying long-term expectations. In doing this, we apply significant judgement in assessing historical cash collections and changes in circumstances that would impact future cash collections such as, but not limited to, commission rates, carrier mix, plan durations, plan cancellations and non-renewals. Changes in LTV result in an increase or decrease to fee income revenue and a corresponding increase or decrease to contract assets. Any significant impact due to changes in the LTV assumptions are recognized in revenue (i) in the period of the change; and (ii) to the extent we do not believe a significant reversal is probable. Costs to Fulfill a Contract Costs to fulfill a contract include commissions owed to independent licensed agents or affinity partners that are contracted by the IHC Agencies. Upon the submission of a completed insurance application, the sales and marketing performance obligation is complete and the resultant estimated lifetime commission costs incurred are expensed and a corresponding commission liability is recorded on the Condensed Consolidated Balance Sheet. As policyholders continue their policy and remit monthly premium payments, the Company receives its commissions from the insurance carrier. Commissions owed to the agent or affinity partner are then paid and the corresponding liability is reduced. Judgement is required to estimate total expected lifetime commissions based on policy duration assumptions. At June 30, 2021 and December 31, 2020, the aforementioned commission liability was $2,858,000 and $2,362,000, respectively, and is included in accounts payable, accruals and other liabilities on the Condensed Consolidated Balance Sheet. Contract Asset Contract assets primarily relate to our commission revenues for the sales of senior products, such as Medicare Advantage and Medicare Supplement plans and ACA plans, which began in 2020. When commission revenue for the sales of these products is recognized, a corresponding contract asset is recorded in other assets on the Condensed Consolidated Balance Sheet. The timing of revenue differs from the collection of commissions. As policyholders continue their policy and remit monthly premium payments, the Company receives its commissions from the insurance carrier and the contract asset is reduced. The following table summarizes the contract asset activity for the period indicated (in thousands). Six Months Ended June 30, 2021 Beginning Balance $ 7,760 Commissions recognized during the period 4,708 Commission adjustments related to prior periods (418) Cash receipts (3,251) Ending Balance $ 8,799 Remaining Performance Obligations Deferred revenues are recorded in connection with certain terminable contracts and the right to use our INSX enrollment platform. At June 30, 2021 and December 31, 2020, deferred revenues are immaterial and expected to be fully recognized within the next 12 months.

Income Tax Disclosure _Text Blo

Income Tax Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Income Tax Disclosure	Note 11. Income Taxes The provisions for income taxes shown in the Condensed Consolidated Statements of Income were computed by applying the effective tax rate expected to be applicable for the reporting periods. Differences between the Federal statutory income tax rate and the Company’s effective income tax rate are principally from the dividends received deduction and tax-exempt interest income, state and local income taxes, and compensation related tax provisions. December 31, 2020, AMIC had Federal net operating loss carryforwards of approximately $46,116,000 and a corresponding valuation allowance of $8,281,000 related to those net operating loss carryforwards that, in the judgment of management, were not considered realizable. On June 30, 2021, the Company sold PetPartners and recorded a pretax gain of $74,534,000 (See Note 2). As a result, AMIC decreased its valuation allowance by $8,281,000 and utilized the $46,116,000 of its outstanding Federal net operating loss carryforwards. Total income tax expense related to the pretax gain on disposal of discontinued operations was $11,841,000. The primary differences between the Federal statutory income tax rate and the Company’s effective income tax rate related to the gain on disposal of discontinued operations are the result of AMIC’s decrease in its valuation allowance, partially offset by the non-deductibility of goodwill and other expenses related to the disposal. The effective income tax rates related to losses from continuing operations in 2021 were impacted by tax benefits from exercises of share-based compensation and state and local income tax benefits on certain subsidiaries. In 2020, the effective income tax rates related to losses from continuing operations reflect a benefit from capital losses attributable to the sale of a subsidiary, partially offset by certain non-deductible expenses recorded in connection with a Regulatory Settlement Agreement. On March 27, 2020, as part of the business stimulus package in response to the COVID-19 pandemic, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security ("CARES") Act. The CARES Act established new tax provisions including, but not limited to: (1) five-year carryback of net operating losses ("NOLs") generated in 2018, 2019 and 2020; (2) accelerated refund of alternative minimum tax (AMT) credit carryforwards; and (3) retroactive changes to allow accelerated depreciation for certain depreciable property. At this time, the legislation does not have a material impact on the Company due to the lack of taxable losses in the stated carryback eligible tax years and the fact that the Company was already expecting to receive a cash benefit for the remaining AMT credits in the fiscal 2018 tax year return. The New York State Department of Taxation and Finance has selected the Company’s 2015 and 2016 NYS returns for audit.

Liability for Future Policy Ben

Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Liability for Future Policy Benefits and Unpaid Claims Disclosure	Note 12. Policy Benefits and Claims Policy benefits and claims is the liability for unpaid loss and loss adjustment expenses. It is comprised of unpaid claims and estimated incurred but not reported (“IBNR”) reserves. Summarized below are the changes in the total liability for policy benefits and claims for the periods indicated (in thousands). Amounts incurred below do not include expenses for policy benefits and costs incurred for the Company’s life, annuity and other long-duration contracts. In addition, certain loss adjustment expenses related to short-duration contracts that are included in amounts incurred below are classified as selling general and administrative expenses on the Condensed Consolidated Statements of Income. For the Six Months Ended June 30, 2021 Specialty Group All Other Health Disability Lines Total Balance at beginning of year $ 31,680 $ 80,976 $ 20,301 $ 132,957 Less: reinsurance recoverable 1,776 22,472 11,878 36,126 Net balance at beginning of year 29,904 58,504 8,423 96,831 Amount incurred, related to: Current year 16,631 20,031 11,947 48,609 Prior years (4,634) (4,033) (1,132) (9,799) Total incurred 11,997 15,998 10,815 38,810 Amount paid, related to: Current year 4,461 3,922 6,885 15,268 Prior years 12,080 11,488 3,667 27,235 Total paid 16,541 15,410 10,552 42,503 Net balance at end of period 25,360 59,092 8,686 93,138 Plus: reinsurance recoverable 1,161 22,492 11,024 34,677 Balance at end of period $ 26,521 $ 81,584 $ 19,710 $ 127,815 For the Six Months Ended June 30, 2020 Specialty Group All Other Health Disability Lines Total Balance at beginning of year $ 35,530 $ 80,079 $ 19,874 $ 135,483 Less: reinsurance recoverable 1,717 23,322 11,954 36,993 Net balance at beginning of year 33,813 56,757 7,920 98,490 Amount incurred, related to: Current year 24,522 19,093 11,182 54,797 Prior years (1,972) (1,553) (3,201) (6,726) Total incurred 22,550 17,540 7,981 48,071 Amount paid, related to: Current year 7,064 4,010 4,979 16,053 Prior years 17,530 12,125 2,155 31,810 Total paid 24,594 16,135 7,134 47,863 Net balance at end of period 31,769 58,162 8,767 98,698 Plus: reinsurance recoverable 1,802 22,463 11,074 35,339 Balance at end of period $ 33,571 $ 80,625 $ 19,841 $ 134,037 Since unpaid loss and loss adjustment expenses are estimates, actual losses incurred may be more or less than the Company’s previously developed estimates and is referred to as either unfavorable or favorable development, respectively. Net favorable (unfavorable) development in the Specialty Health segment, as depicted in the tables above, is comprised of the following lines of business for the years indicated (in thousands): Six Months Ended June 30, Specialty Health segment: 2021 2020 Short-term Medical (“STM”) $ 1,676 $ 286 Occupational Accident 963 798 Fixed Indemnity Limited Benefit 862 (736) Limited Medical 197 241 Critical Illness 196 397 Group Gap 356 513 All other specialty health lines 384 473 Total Specialty Health segment $ 4,634 $ 1,972 In both 2021 and 2020, net favorable development in the various lines of the Specialty Health segment shown above are primarily due to better than expected claim development. In 2021, experience in STM continues to be better than expected and severity has been relatively low. In 2021, favorable development of $4,033,000 in the group disability business is primarily due to lower frequency and severity in both the short-term disability (“STD”) and the long-term disability (“LTD”) lines. In 2020, favorable development in the group disability business is primarily due to a reduction in open claims, specifically new claims, in the LTD line, partially offset by an increase in the overall frequency and severity of claims in the STD line. All other lines, primarily life and other individual health products and including our medical stop-loss business in run-off, experienced favorable development in 2021 and 2020. The favorable development in 2020 is primarily related to the group term life business due to continued improvements in experience and updated assumptions for the Paid-Up Life business. Included in the preceding rollforward of the Company’s liability for policy benefits and claims are the policy benefits and claims activity associated with the Company’s health insurance lines. These are embedded within the Specialty Health segment. The table below summarizes the components of the change in the liability for policy benefits and claims that are specific to health insurance claims for the periods indicated (in thousands). Specialty Health Segment Health Insurance Claims Six Months Ended June 30, 2021 2020 Balance at beginning of year $ 28,295 $ 31,259 Less: reinsurance recoverable 1,766 1,113 Net balance at beginning of year 26,529 30,146 Amount incurred, related to: Current year 15,818 23,627 Prior years (3,658) (1,184) Total incurred 12,160 22,443 Amount paid, related to: Current year 4,319 8,260 Prior years 11,992 16,382 Total paid 16,311 24,642 Net balance at end of period 22,378 27,947 Plus: reinsurance recoverable 1,158 1,406 Balance at end of period $ 23,536 $ 29,353 The liability for the IBNR plus expected development on reported claims associated with the Company’s health insurance claims is $22,378,000 at June 30, 2021.

Stockholders' Equity Note Discl

Stockholders' Equity Note Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Stockholders' Equity Note Disclosure	Note 13. Stockholders’ Equity Accumulated Other Comprehensive Income (Loss) Other comprehensive income (loss) includes the after-tax net unrealized gains and losses on investment securities available-for-sale, including the subsequent increases and decreases in fair value of available-for-sale securities previously impaired and the non-credit related component of other-than-temporary impairments of fixed maturities. Changes in the balances of accumulated other comprehensive income, shown net of taxes, for the periods indicated are as follows (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Beginning balance $ 2,268 $ 1,101 $ 4,197 $ 1,212 Other comprehensive income (loss): Other comprehensive income (loss) before reclassifications 784 1,810 (1,013) 2,544 Amounts reclassified from accumulated OCI 168 (57) 36 (902) Net other comprehensive income (loss) 952 1,753 (977) 1,642 Ending balance $ 3,220 $ 2,854 $ 3,220 $ 2,854 Presented below are the amounts reclassified out of accumulated other comprehensive income (loss) and recognized in earnings for each of the periods indicated (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Unrealized gains (losses) on available-for-sale securities reclassified during the period to the following income statement line items: Net investment gains (losses) $ (125) $ 47 $ 47 $ 284 Income (loss) from continuing operations before income taxes (125) 47 47 284 Income tax expense (benefit) (28) 10 9 60 Income (loss) from continuing operations, net of tax (97) 37 38 224 Total pretax income (loss) from discontinued operations (90) 25 (94) 858 Income tax expense (benefit) on discontinued operations (19) 5 (20) 180 Income from discontinued operations, net of tax (71) 20 (74) 678 Net income (loss) $ (168) $ 57 $ (36) $ 902

Cash Flow, Supplemental Disclos

Cash Flow, Supplemental Disclosures [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Cash Flow, Supplemental Disclosures	Note 14. Supplemental Disclosures of Cash Flow Information Net cash payments for income taxes were $59,000 and $55,000 during the six months ended June 30, 2021 and 2020, respectively.

Commitments and Contingencies D

Commitments and Contingencies Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Commitments and Contingencies Disclosure	Note 15. Contingencies Third Party Administrator A third party administrator with whom we formerly did business (“Plaintiff” or “TPA”) commenced an action on May 17, 2017 in the United States District Court, Northern District of Texas, Dallas Division (the “Texas Action”), naming IHC, Madison National Life, Standard Security Life, and Independence Brokerage Group, Inc. (formerly IHC Carrier Solutions, Inc.) as defendants (“Defendants”). The Plaintiff seeks contractual payments allegedly owed by the Defendants totaling at least $3,082,000 through 2014, plus additional amounts for 2015 and 2016, and exemplary and punitive damages as allowed by law and fees and costs. The court had previously stayed the proceedings during the pendency of two arbitrations. The first arbitration resulted in a judicially-confirmed award in favor of Standard Security Life and Madison National Life in the amount of $5,641,000, which the Plaintiff has satisfied. The Company received payment on September 9, 2020 and recorded it in other income on the Consolidated Statement of Income in the third quarter of 2020. The second arbitration resulted in no monetary obligations owed by any of the parties. The Plaintiff has filed a motion for leave to file a Second Amended Complaint. The Defendants have until August 9, 2021 to file an opposition to the motion for leave to amend. Multistate Market Conduct Examination (“MCE”) As previously disclosed, our subsidiaries Standard Security Life, Madison National Life and Independence American Insurance Company were selected for MCE related to our short-term medical (“STM”), limited medical and fixed indemnity limited health insurance products for the period of January 1, 2014 through September 30, 2017. The insurance departments of five jurisdictions (Delaware, Wisconsin, District of Columbia, Kansas and South Dakota) served as lead states, and the District of Columbia Department of Insurance, Securities and Banking and the Delaware Department of Insurance served as the managing lead states of the MCE. In addition to the five lead states, 37 other states participated in the MCE. Each of Standard Security Life, Madison National Life and Independence American Insurance Company responded to inquiries and document production requests in the MCE and proactively communicated and cooperated with the applicable regulatory agencies for the MCE. Each of these subsidiaries also provided a detailed action plan to regulators that summarized its enhanced compliance and control mechanisms. In an effort to avoid long‐term litigation and/or administrative proceedings that would be required to resolve disputes between Standard Security Life, Madison National Life and Independence American Insurance Company and the states involved in the MCE, the Lead States and Standard Security Life, Madison National Life and Independence American Insurance Company entered into separate RSAs on July 14, 2020. The RSAs require the implementation of a compliance plan, impose certain requirements related to specified business practices and monetary payments. The thirty-seven participating states adopted the RSAs. The Company accrued $3,660,000 in accounts payable, accruals and other liabilities on the Consolidated Balance Sheet in the second quarter of 2020 and processed payment in October 2020. As set forth in the RSAs, Standard Security Life, Madison National Life and Independence American Insurance Company deny any wrongdoing or violation of any applicable laws or regulations, and the entry into the RSAs is not an admission or acknowledgment of any wrongdoing or liability. In accordance with the RSAs, the Monitoring Period commenced and Standard Security Life, Madison National Life and Independence American Insurance Company continue to comply.

Segment Reporting Disclosure _T

Segment Reporting Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Segment Reporting Disclosure	Note 16. Segment Reporting The Insurance Group principally engages in the life and health insurance business. Taxes and general expenses associated with parent company activities are included in Corporate. Identifiable assets by segment are those assets that are utilized in each segment and are allocated based upon the mean reserves and liabilities of each such segment. Corporate assets are composed principally of cash equivalents, resale agreements, fixed maturities, equity securities, partnership interests and certain other investments. Information by business segment is presented below for the periods indicated (in thousands): Three Months Ended Six Months Ended June 30, June 30, 20 21 2020 2021 2020 Revenues: Specialty Health $ 23,862 $ 30,718 $ 50,133 $ 62,924 Group disability and life 25,143 24,076 50,264 48,161 Individual life, annuities and other (A) 183 490 392 808 Corporate 268 897 791 1,512 49,456 56,181 101,580 113,405 Net investment gains (losses) (126) 274 91 117 Total revenues $ 49,330 $ 56,455 $ 101,671 $ 113,522 Income before income taxes Specialty Health (C) $ (841) $ (5,329) $ (2,732) $ (5,935) Group disability and life 3,770 4,353 6,900 6,190 Individual life, annuities and other (A) (B) (263) (140) (247) (283) Corporate (3,244) (2,016) (5,056) (3,229) (578) (3,132) (1,135) (3,257) Net investment gains (losses) (126) 274 91 117 Loss from continuing operations before income taxes $ (704) $ (2,858) $ (1,044) $ (3,140) (A) (B) (C)

Subsequent Events _Text Block_

Subsequent Events [Text Block]	6 Months Ended
	Jun. 30, 2021
Notes
Subsequent Events	Note 17. Subsequent Events On July 14, 2021, IHC and its wholly owned subsidiary ICC entered into a Stock Purchase Agreement with Horace Mann Educators Corporation to sell all of the issued and outstanding capital stock of Madison National Life, a Wisconsin insurance company wholly owned by ICC, for an aggregate purchase price of $172,500,000 in cash. In addition, if Madison National Life reaches specified financial targets in 2023, IHC will receive an additional purchase price of up to $12,500,000. The transaction has been approved by the Board of Directors of IHC, and IHC’s majority stockholders have entered into a voting agreement under which such majority stockholders agreed to approve the transaction. The closing is expected no earlier than January 1, 2022. The transaction is subject to customary closing conditions, including applicable regulatory approvals, one of which is the approval by the Wisconsin Office of the Commissioner of Insurance. The aforementioned disposal plan represents a strategic shift that will have a major effect on the Company’s operations and financial results and as such, will qualify for reporting as discontinued operations in the third quarter 2021.

Organization, Consolidation, _2

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: Basis of Accounting, Policy [Policy Text Block] (Policies)	6 Months Ended
	Jun. 30, 2021
Policies
Basis of Accounting, Policy	The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles ("GAAP") for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. IHC’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements. During the second quarter of 2021, the Board of Directors committed to various plans for the disposal of several business operations (see Note 2). Each plan represents a strategic shift that will have a major effect on the Company’s operations and financial results and as such, they each qualify for reporting as discontinued operations in the second quarter 2021. The assets, liabilities, and related income and expenses associated with each disposal group are presented as discontinued operations in the accompanying condensed consolidated financial statements and Notes thereto for all periods presented. In March 2020, the World Health Organization declared the outbreak of COVID-19 a global health pandemic and the United States declared a national health emergency. COVID-19 has led to largescale disruption in the global economy, market instability and widespread unemployment in the United States. The COVID-19 outbreak continues to be a fluid situation and as it evolves, the duration of COVID-19 and its potential effects on our business cannot be certain. Regulatory mandates have affected, and we anticipate will continue to impact, the insurance industry. We currently cannot predict if there will be a material impact to our business, results of operations or financial condition in future reporting periods. Consequently, future changes in market conditions may impact estimates used in the preparation of our financial statements associated with evaluations of goodwill and other intangible assets for impairment, estimates associated with the determination of valuation allowances related to net operating loss carryforwards, and estimates of certain losses under insurance contracts. These estimates may all be subject to substantial adjustments in future periods. In addition, volatile market conditions may result in declines in the fair value of our investment portfolio and possible impairments of certain securities. In the opinion of management, all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been included. The condensed consolidated results of operations for the three months and six months ended June 30, 2021 are not necessarily indicative of the results to be anticipated for the entire year.

Organization, Consolidation, _3

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: Reclassification, Policy [Policy Text Block] (Policies)	6 Months Ended
	Jun. 30, 2021
Policies
Reclassification, Policy	Certain amounts in prior year’s condensed consolidated financial statements and Notes thereto have been reclassified to conform to the 2021 presentation, primarily for the effects of discontinued operations.

Organization, Consolidation, _4

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: New Accounting Pronouncements, Policy [Policy Text Block] (Policies)	6 Months Ended
	Jun. 30, 2021
Policies
New Accounting Pronouncements, Policy	Recently Adopted Accounting Standards In December 2019, the Financial Accounting Standard Board (“FASB”) issued guidance to simplify the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes, the requirement to allocate current and deferred tax expense to legal entities not subject to tax in its separate financial statements, enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. Recently Issued Accounting Standards Not Yet Adopted In August 2018, the FASB issued guidance to improve existing measurements, presentation and disclosure requirements for long-duration contracts issued by insurance entities. The amendments in this guidance requires an entity to (1) review and update assumptions used to measure cash flows at least annually as well as update the discount rate assumption at each reporting date; (2) measure market risk benefits associated with deposit contracts at fair value; (3) disclose liability rollforwards and information about significant inputs, judgements assumptions, and methods used in measurement. Additionally, it simplifies the amortization of deferred acquisition costs and other balances on a constant level basis over the expected term of the related contracts. In 2019, the FASB delayed the original effective dates. For smaller reporting companies, the amendments in this guidance are now effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Upon adoption, the amendments in this guidance should be applied to contracts in-force as of the beginning of the earliest period presented with a cumulative adjustment to beginning retained earnings. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. In June 2016, the FASB issued guidance requiring financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. An allowance for credit losses will be deducted from the amortized cost basis to present the net carrying value at the amount expected to be collected with changes in the allowance recorded in earnings. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than the currently applied U.S. GAAP method of taking a permanent impairment of the security, which would be limited to the amount by which fair value is below the amortized cost. Certain existing requirements used to evaluate credit losses have been removed. In 2019, the FASB provided transition relief by providing entities with an option to irrevocably elect the fair value option on an instrument-by-instrument basis for eligible instruments upon adoption and delayed the original effective dates. For smaller reporting companies, the amendments in this guidance are now effective for fiscal years beginning after December 15, 2022, including interim periods within those years. Early adoption is permitted. The amendments in this guidance should be applied through a cumulative effect adjustment to retained earnings upon adoption as of the beginning of the first reporting period in which the guidance is effective. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements.

Disposal Groups, Including Di_2

Disposal Groups, Including Discontinued Operations, Disclosure: Disposal Groups, Including Discontinued Operations (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Disposal Groups, Including Discontinued Operations	The following is a reconciliation, by disposal group, of the carrying amounts of major classes of assets and liabilities included in discontinued operations on the Condensed Consolidated Balance Sheets for the periods indicated (in thousands): June 30, 2021 SSL Sale Pets Sale Total Major classes of assets: Investments and cash $ 164,346 $ 144,688 $ 309,034 Goodwill - 41,716 41,716 Other assets 30,020 35,392 65,412 Assets attributable to discontinued operations $ 194,366 $ 221,796 $ 416,162 Major classes of liabilities: Policy benefits and claims $ 56,987 $ 12,743 $ 69,730 Unearned premiums 26,778 6,080 32,858 Other liabilities 12,500 5,092 17,592 Liabilities attributable to discontinued operations $ 96,265 $ 23,915 $ 120,180 December 31, 2020 SSL Sale Pets Sale Total Major classes of assets included in discontinued operations: Investments and cash $ 114,916 $ 149,844 $ 264,760 Goodwill - 62,414 62,414 Other assets 18,787 29,730 48,517 Assets attributable to discontinued operations $ 133,703 $ 241,988 $ 375,691 Major classes of liabilities included in discontinued operations: Policy benefits and claims $ 34,500 $ 11,775 $ 46,275 Unearned premiums 5,208 5,629 10,837 Other liabilities 9,316 9,511 18,827 Liabilities attributable to discontinued operations $ 49,024 $ 26,915 $ 75,939 The following is a reconciliation, by disposal group, of the major line items constituting the pretax profit of discontinued operations to the income from discontinued operations, net of tax, as shown on the Condensed Consolidated Statements of Income for the periods indicated (in thousands): For the Three Months Ended June 30, 2021 SSL Sale Pets Sale Total Revenues $ 50,342 $ 33,080 $ 83,422 Expenses: Insurance benefits, claims and reserves 24,341 18,442 42,783 Selling, general and administrative expenses 7,394 14,592 21,986 Pretax income of discontinued operations during phase-out 18,607 46 18,653 Pretax provision for loss on disposal (402) (410) (812) Pretax gain on disposal of discontinued operations - 74,534 74,534 Total pretax income from discontinued operations 18,205 74,170 92,375 Income tax expense on discontinued operations 3,836 11,734 15,570 Income from discontinued operations, net of tax $ 14,369 $ 62,436 $ 76,805 For the Three Months Ended June 30, 2020 SSL Sale Pets Sale Total Revenues $ 30,442 $ 20,407 $ 50,849 Expenses: Insurance benefits, claims and reserves 22,152 11,098 33,250 Selling, general and administrative expenses 6,150 7,855 14,005 Pretax income of discontinued operations during phase-out 2,140 1,454 3,594 Pretax provision for loss on disposal - - - Pretax gain on disposal of discontinued operations - - - Total pretax income from discontinued operations 2,140 1,454 3,594 Income tax expense on discontinued operations 822 442 1,264 Income from discontinued operations, net of tax $ 1,318 $ 1,012 $ 2,330 For the Six Months Ended June 30, 2021 SSL Sale Pets Sale Total Revenues $ 93,738 $ 61,999 $ 155,737 Expenses: Insurance benefits, claims and reserves 53,865 34,374 88,239 Selling, general and administrative expenses 14,850 26,796 41,646 Pretax income of discontinued operations during phase-out 25,023 829 25,852 Pretax provision for loss on disposal (402) (410) (812) Pretax gain on disposal of discontinued operations - 74,534 74,534 Total pretax income from discontinued operations 24,621 74,953 99,574 Income tax expense on discontinued operations 5,151 11,875 17,026 Income from discontinued operations, net of tax $ 19,470 $ 63,078 $ 82,548 For the Six Months Ended June 30, 2020 SSL Sale Pets Sale Total Revenue $ 59,943 $ 37,838 $ 97,781 Expenses: Insurance benefits, claims and reserves 40,560 20,459 61,019 Selling, general and administrative expenses 13,004 14,515 27,519 Pretax income of discontinued operations during phase-out 6,379 2,864 9,243 Pretax provision for loss on disposal - - - Pretax gain on disposal of discontinued operations - - - Total pretax income from discontinued operations 6,379 2,864 9,243 Income tax expense on discontinued operations 1,689 741 2,430 Income from discontinued operations, net of tax $ 4,690 $ 2,123 $ 6,813

Earnings Per Share _Text Bloc_2

Earnings Per Share [Text Block]: Earnings Per Share, Schedule Of Net Income Attributable To Parent (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Earnings Per Share, Schedule Of Net Income Attributable To Parent	Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Income from continuing operations attributable to IHC $ (436) $ (1,835) $ (612) $ (1,987) Income from discontinued operations attributable to IHC $ 76,907 $ 2,256 $ 82,704 $ 6,686 Net income attributable to IHC $ 76,471 $ 421 $ 82,092 $ 4,699

Cash and Cash Equivalents Dis_2

Cash and Cash Equivalents Disclosure: Schedule of Cash and Cash Equivalents (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Cash and Cash Equivalents	June 30, 2021 2020 Cash and cash equivalents $ 22,834 $ 11,655 Restricted cash in other assets 418 985 Cash, cash equivalents and restricted cash in discontinued operations 3,773 11,563 Total cash, cash equivalents and restricted cash including discontinued operations $ 27,025 $ 24,203

Investments in Debt and Marke_2

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Debt Securities, Available-for-sale [Table Text Block] (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Debt Securities, Available-for-sale	June 30, 2021 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 75,245 $ 1,583 $ (779) $ 76,049 CMOs – residential (1) 3,071 118 (5) 3,184 U.S. Government obligations 23,029 273 - 23,302 Agency MBS - residential (2) 35 - (4) 31 GSEs (3) 2,969 - (84) 2,885 States and political subdivisions 74,086 1,261 (384) 74,963 Foreign government obligations 3,144 151 - 3,295 Total fixed maturities $ 181,579 $ 3,386 $ (1,256) $ 183,709 December 31, 2020 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 91,802 $ 2,174 $ (1,302) $ 92,674 CMOs – residential (1) 3,439 146 (2) 3,583 U.S. Government obligations 23,397 414 - 23,811 Agency MBS - residential (2) 39 - (5) 34 GSEs (3) 3,055 - (81) 2,974 States and political subdivisions 82,910 1,768 (452) 84,226 Foreign government obligations 3,211 206 - 3,417 Total fixed maturities $ 207,853 $ 4,708 $ (1,842) $ 210,719 (1) (2) (3)

Investments in Debt and Marke_3

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Investments Classified by Contractual Maturity Date (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Investments Classified by Contractual Maturity Date	AMORTIZED FAIR COST VALUE Due in one year or less $ 36,481 $ 36,938 Due after one year through five years 87,377 89,128 Due after five years through ten years 20,124 20,292 Due after ten years 31,522 31,252 Fixed maturities with no single maturity date 6,075 6,099 $ 181,579 $ 183,709

Investments in Debt and Marke_4

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	June 30, 2021 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 19,962 $ 740 $ 4,503 $ 39 $ 24,465 $ 779 CMOs-residential 707 5 - - 707 5 Agency MBS - residential 31 4 - - 31 4 GSEs - 2,886 84 2,886 84 States and political subdivisions 10,319 76 8,813 308 19,132 384 Fixed maturities in an unrealized loss position $ 31,019 $ 825 $ 16,202 $ 431 $ 47,221 $ 1,256 Number of fixed maturities in an unrealized loss position 9 14 23 December 31, 2020 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 23,591 $ 458 $ 8,845 $ 844 $ 32,436 $ 1,302 CMOs-residential 748 2 - - 748 2 Agency MBS - residential 34 5 - - 34 5 GSEs - - 2,974 81 2,974 81 States and political subdivisions 16,983 150 6,108 302 23,091 452 Fixed maturities in an unrealized loss position $ 41,356 $ 615 $ 17,927 $ 1,227 $ 59,283 $ 1,842 Number of fixed maturities in an unrealized loss position 20 13 33

Investments in Debt and Marke_5

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Realized Gain (Loss) on Investments (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Realized Gain (Loss) on Investments	Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Realized gains (losses): Fixed maturities available-for-sale $ (126) $ 50 $ 46 $ 284 Equity securities - - 292 - Total realized gains (losses) on debt and equity securities (126) 50 338 284 Unrealized gains (losses) on equity securities - 214 (247) (184) Gains (losses) on debt and equity securities (126) 264 91 100 Gains (losses) on other investments - 10 - 17 Net investment gains $ (126) $ 274 $ 91 $ 117

Fair Value Disclosures _Text _2

Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Fair Value, Assets Measured on Recurring Basis	June 30, 2021 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 76,049 $ - $ 76,049 CMOs - residential - 3,184 - 3,184 US Government obligations - 23,302 - 23,302 Agency MBS - residential - 31 - 31 GSEs - 2,885 - 2,885 States and political subdivisions - 73,949 1,014 74,963 Foreign government obligations - 3,295 - 3,295 Total fixed maturities - 182,695 1,014 183,709 Total Financial Assets $ - $ 182,695 $ 1,014 $ 183,709 December 31, 2020 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 92,674 $ - $ 92,674 CMOs - residential - 3,583 - 3,583 US Government obligations - 23,811 - 23,811 Agency MBS - residential - 34 - 34 GSEs - 2,974 - 2,974 States and political subdivisions - 83,130 1,096 84,226 Foreign government obligations - 3,417 - 3,417 Total fixed maturities - 209,623 1,096 210,719 Equity securities: Common stocks 1,753 - - 1,753 Total equity securities 1,753 - - 1,753 Total Financial Assets $ 1,753 $ 209,623 $ 1,096 $ 212,472

Fair Value Disclosures _Text _3

Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	Three Months Ended June 30, 2021 2020 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning b alance $ 1,055 $ 1,055 $ 1,214 $ 1,214 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (4) (4) (5) (5) Repayments and amortization of fixed maturities (37) (37) (34) (34) Balance at end of period $ 1,014 $ 1,014 $ 1,175 $ 1,175 Six Months Ended June 30, 2021 2020 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning b alance $ 1,096 $ 1,096 $ 1,251 $ 1,251 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (8) (8) (9) (9) Repayments and amortization of fixed maturities (74) (74) (67) (67) Balance at end of period $ 1,014 $ 1,014 $ 1,175 $ 1,175

Fair Value Disclosures _Text _4

Fair Value Disclosures [Text Block]: Fair Value, by Balance Sheet Grouping (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Fair Value, by Balance Sheet Grouping	June 30, 2021 December 31, 2020 Level 1 Level 2 Level 1 Level 2 Fair Fair Carrying Fair Fair Carrying Value Value Value Value Value Value FINANCIAL ASSETS: Short-term investments $ 1,550 $ - $ 1,550 $ 1,568 $ - $ 1,568 Securities purchased under agreements to resell 70,323 - 70,323 33,038 - 33,038 FINANCIAL LIABILITIES: Funds on deposit $ - $ 142,155 $ 142,155 $ - $ 141,376 $ 141,376 Other policyholders’ funds - 11,988 11,988 - 12,001 12,001

Business Combination Disclosu_2

Business Combination Disclosure: Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Tables)	6 Months Ended
	Jun. 30, 2021
Abacus
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	Other assets $ 350 Total identifiable assets 350 Other liabilities 575 Total liabilities 575 Net identifiable assets (liabilities) acquired $ (225)
Torchlight Technology Group Acquisition Member
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	Cash $ 333 Intangible assets 2,700 Other assets 2,132 Total identifiable assets 5,165 Other liabilities 1,227 Total liabilities 1,227 Net identifiable assets acquired $ 3,938

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Finite-Lived Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Finite-Lived Intangible Assets	June 30, 2021 December 31, 2020 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Finite-lived Intangible Assets: Agent and broker relationships $ 6,583 $ 4,599 $ 7,583 $ 5,385 Software systems 1,500 294 1,500 167 Total finite-lived $ 8,083 $ 4,893 $ 9,083 $ 5,552

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Indefinite-Lived Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Indefinite-Lived Intangible Assets	June 30, December 31, 2021 2020 Indefinite-lived Intangible Assets: Insurance licenses $ 477 $ 477 Total indefinite-lived $ 477 $ 477

Revenue from Contract with Cu_2

Revenue from Contract with Customer: Disaggregation of Revenue (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Disaggregation of Revenue	Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Commissions $ 1,416 1,932 4,297 $ 3,672 Administrative Fees 80 581 177 1,069 Marketing Fees 254 292 559 643 Enrollment Platform Fees 529 455 1,029 973 Lead and Referral Fees 2,633 588 4,945 854 Payment Plan, Application and Other Fees 32 59 72 130 Total Fee Income $ 4,944 3,907 11,079 $ 7,341

Revenue from Contract with Cu_3

Revenue from Contract with Customer: Contract with Customer, Contract Asset, Contract Liability, and Receivable (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Contract with Customer, Contract Asset, Contract Liability, and Receivable	Six Months Ended June 30, 2021 Beginning Balance $ 7,760 Commissions recognized during the period 4,708 Commission adjustments related to prior periods (418) Cash receipts (3,251) Ending Balance $ 8,799

Liability for Future Policy B_2

Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Tables)	6 Months Ended
	Jun. 30, 2021
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense	For the Six Months Ended June 30, 2021 Specialty Group All Other Health Disability Lines Total Balance at beginning of year $ 31,680 $ 80,976 $ 20,301 $ 132,957 Less: reinsurance recoverable 1,776 22,472 11,878 36,126 Net balance at beginning of year 29,904 58,504 8,423 96,831 Amount incurred, related to: Current year 16,631 20,031 11,947 48,609 Prior years (4,634) (4,033) (1,132) (9,799) Total incurred 11,997 15,998 10,815 38,810 Amount paid, related to: Current year 4,461 3,922 6,885 15,268 Prior years 12,080 11,488 3,667 27,235 Total paid 16,541 15,410 10,552 42,503 Net balance at end of period 25,360 59,092 8,686 93,138 Plus: reinsurance recoverable 1,161 22,492 11,024 34,677 Balance at end of period $ 26,521 $ 81,584 $ 19,710 $ 127,815 For the Six Months Ended June 30, 2020 Specialty Group All Other Health Disability Lines Total Balance at beginning of year $ 35,530 $ 80,079 $ 19,874 $ 135,483 Less: reinsurance recoverable 1,717 23,322 11,954 36,993 Net balance at beginning of year 33,813 56,757 7,920 98,490 Amount incurred, related to: Current year 24,522 19,093 11,182 54,797 Prior years (1,972) (1,553) (3,201) (6,726) Total incurred 22,550 17,540 7,981 48,071 Amount paid, related to: Current year 7,064 4,010 4,979 16,053 Prior years 17,530 12,125 2,155 31,810 Total paid 24,594 16,135 7,134 47,863 Net balance at end of period 31,769 58,162 8,767 98,698 Plus: reinsurance recoverable 1,802 22,463 11,074 35,339 Balance at end of period $ 33,571 $ 80,625 $ 19,841 $ 134,037
Specialty Health Segment Member | Health Insurance Product Line
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense	Specialty Health Segment Health Insurance Claims Six Months Ended June 30, 2021 2020 Balance at beginning of year $ 28,295 $ 31,259 Less: reinsurance recoverable 1,766 1,113 Net balance at beginning of year 26,529 30,146 Amount incurred, related to: Current year 15,818 23,627 Prior years (3,658) (1,184) Total incurred 12,160 22,443 Amount paid, related to: Current year 4,319 8,260 Prior years 11,992 16,382 Total paid 16,311 24,642 Net balance at end of period 22,378 27,947 Plus: reinsurance recoverable 1,158 1,406 Balance at end of period $ 23,536 $ 29,353

Liability for Future Policy B_3

Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule Of Prior Year Claims And Claims Adjustment Expense Disclosure (Tables)	6 Months Ended
	Jun. 30, 2021
Specialty Health Segment, All Product Lines
Schedule Of Prior Year Claims And Claims Adjustment Expense Disclosure	Six Months Ended June 30, Specialty Health segment: 2021 2020 Short-term Medical (“STM”) $ 1,676 $ 286 Occupational Accident 963 798 Fixed Indemnity Limited Benefit 862 (736) Limited Medical 197 241 Critical Illness 196 397 Group Gap 356 513 All other specialty health lines 384 473 Total Specialty Health segment $ 4,634 $ 1,972

Stockholders' Equity Note Dis_2

Stockholders' Equity Note Disclosure [Text Block]: Schedule of Accumulated Other Comprehensive Income (Loss) (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Accumulated Other Comprehensive Income (Loss)	Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Beginning balance $ 2,268 $ 1,101 $ 4,197 $ 1,212 Other comprehensive income (loss): Other comprehensive income (loss) before reclassifications 784 1,810 (1,013) 2,544 Amounts reclassified from accumulated OCI 168 (57) 36 (902) Net other comprehensive income (loss) 952 1,753 (977) 1,642 Ending balance $ 3,220 $ 2,854 $ 3,220 $ 2,854

Stockholders' Equity Note Dis_3

Stockholders' Equity Note Disclosure [Text Block]: Reclassification out of Accumulated Other Comprehensive Income (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Reclassification out of Accumulated Other Comprehensive Income	Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Unrealized gains (losses) on available-for-sale securities reclassified during the period to the following income statement line items: Net investment gains (losses) $ (125) $ 47 $ 47 $ 284 Income (loss) from continuing operations before income taxes (125) 47 47 284 Income tax expense (benefit) (28) 10 9 60 Income (loss) from continuing operations, net of tax (97) 37 38 224 Total pretax income (loss) from discontinued operations (90) 25 (94) 858 Income tax expense (benefit) on discontinued operations (19) 5 (20) 180 Income from discontinued operations, net of tax (71) 20 (74) 678 Net income (loss) $ (168) $ 57 $ (36) $ 902

Segment Reporting Disclosure _2

Segment Reporting Disclosure [Text Block]: Schedule of Segment Reporting Information, by Segment (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Segment Reporting Information, by Segment	Three Months Ended Six Months Ended June 30, June 30, 20 21 2020 2021 2020 Revenues: Specialty Health $ 23,862 $ 30,718 $ 50,133 $ 62,924 Group disability and life 25,143 24,076 50,264 48,161 Individual life, annuities and other (A) 183 490 392 808 Corporate 268 897 791 1,512 49,456 56,181 101,580 113,405 Net investment gains (losses) (126) 274 91 117 Total revenues $ 49,330 $ 56,455 $ 101,671 $ 113,522 Income before income taxes Specialty Health (C) $ (841) $ (5,329) $ (2,732) $ (5,935) Group disability and life 3,770 4,353 6,900 6,190 Individual life, annuities and other (A) (B) (263) (140) (247) (283) Corporate (3,244) (2,016) (5,056) (3,229) (578) (3,132) (1,135) (3,257) Net investment gains (losses) (126) 274 91 117 Loss from continuing operations before income taxes $ (704) $ (2,858) $ (1,044) $ (3,140) (A) (B) (C)

Organization, Consolidation, _5

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] (Details)	Jun. 30, 2021
GeneveAffiliatedEntityMember
EntityCommonStockOutstandingOwnershipPercent	62.00%

Disposal Groups, Including Di_3

Disposal Groups, Including Discontinued Operations, Disclosure (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Jul. 29, 2021	May 17, 2021	Apr. 14, 2021	Dec. 31, 2020
Equity Method Investments	$ 33,762	$ 33,762		$ 33,762					$ 0
Discontinued Operation, Tax Effect of Discontinued Operation		15,570	$ 1,264	17,026	$ 2,430
AMICSubsidiariesMember
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount				8,281
Operating Loss Carryforwards									$ 46,116
Discontinued Operations
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax		18,653	3,594	25,852	9,243
Cash Provided by (Used in) Operating Activities, Discontinued Operations				45,917	26,813
Cash Provided by (Used in) Investing Activities, Discontinued Operations				(88,501)	(29,753)
Discontinued Operation, Tax Effect of Discontinued Operation		15,570	1,264	17,026	2,430
Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation				11,841
SSL Sale Member | Discontinued Operations
Disposal Group Including Discontinued Operation, Transaction Price								$ 180,000
Sale Transaction, Statutory Capital And Surplus Target								$ 53,000
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	$ 82,091	82,091		82,091
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax		18,607	2,140	25,023	6,379
Discontinued Operation, Tax Effect of Discontinued Operation		3,836	822	5,151	1,689
SSL Sale Member | Discontinued Operations | Subsequent Event
Sale Transaction, Statutory Capital And Surplus Target						$ 57,000
Pets Sale Member | Discontinued Operations
Discontinued Operation, Equity Method Investment Retained after Disposal, Ownership Interest Prior to Disposal	70.00%
Discontinued Operation, Equity Method Investment Retained after Disposal, Ownership Interest after Disposal	30.00%
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax		46	1,454	829	2,864
Discontinued Operation, Tax Effect of Discontinued Operation		11,734	$ 442	11,875	$ 741
Pets Sale, PetPartners Transaction | AMICSubsidiariesMember
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount				8,281
Pets Sale, PetPartners Transaction | Discontinued Operations
Disposal Group Including Discontinued Operation, Transaction Price							$ 77,000
Disposal Group, Including Discontinued Operation, Consideration	$ 78,779	78,779		78,779
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax				62,693
Disposal Of Discontinued Operation, Transaction Costs				6,070
Loss Contingency Accrual	6,800	6,800		6,800
Pets Sale, PetPartners Transaction | Discontinued Operations | Iguana Capital, Inc Member
Equity Method Investments	$ 33,762	$ 33,762		$ 33,762
Pets Sale, IAHC Transaction | Discontinued Operations
Disposal Group Including Discontinued Operation, Transaction Price							$ 190,400

Disposal Groups, Including Di_4

Disposal Groups, Including Discontinued Operations, Disclosure: Disposal Groups, Including Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Disposal Group, Including Discontinued Operation, Assets
Disposal Group, Including Discontinued Operation, Assets	$ 416,162		$ 416,162		$ 375,691
Disposal Group, Including Discontinued Operation, Liabilities
Disposal Group, Including Discontinued Operation, Liabilities	120,180		120,180		$ 75,939
Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax			812	$ 0
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax			(74,534)	0
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	92,375	$ 3,594	99,574	9,243
Discontinued Operation, Tax Effect of Discontinued Operation	15,570	1,264	17,026	2,430
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	76,805	2,330	82,548	6,813
Discontinued Operations
Disposal Group, Including Discontinued Operation, Assets
Disposal Group, Including Discontinued Operation, Cash And Invesments	309,034		309,034			$ 264,760
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent	41,716		41,716			62,414
Disposal Group, Including Discontinued Operation, Other Assets	65,412		65,412			48,517
Disposal Group, Including Discontinued Operation, Assets	416,162		416,162			375,691
Disposal Group, Including Discontinued Operation, Liabilities
Disposal Group, Including Discontinued Operation, Policy Benefits And Claims	69,730		69,730			46,275
Disposal Group, Including Discontinued Operation,Unearned Premiums	32,858		32,858			10,837
Disposal Group, Including Discontinued Operation, Other Liabilities	17,592		17,592			18,827
Disposal Group, Including Discontinued Operation, Liabilities	120,180		120,180			75,939
Disposal Group, Including Discontinued Operation, Revenue	83,422	50,849	155,737	97,781
Disposal Group, Including Discontinued Operation,Insurance Benefits, Claims And Reserves	42,783	33,250	88,239	61,019
Disposal Group, Including Discontinued Operation, General and Administrative Expense	21,986	14,005	41,646	27,519
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax	18,653	3,594	25,852	9,243
Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax	812	0	812	0
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax	74,534	0	74,534	0
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	92,375	3,594	99,574	9,243
Discontinued Operation, Tax Effect of Discontinued Operation	15,570	1,264	17,026	2,430
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	76,805	2,330	82,548	6,813
SSL Sale Member | Discontinued Operations
Disposal Group, Including Discontinued Operation, Assets
Disposal Group, Including Discontinued Operation, Cash And Invesments	164,346		164,346			114,916
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent	0		0			0
Disposal Group, Including Discontinued Operation, Other Assets	30,020		30,020			18,787
Disposal Group, Including Discontinued Operation, Assets	194,366		194,366			133,703
Disposal Group, Including Discontinued Operation, Liabilities
Disposal Group, Including Discontinued Operation, Policy Benefits And Claims	56,987		56,987			34,500
Disposal Group, Including Discontinued Operation,Unearned Premiums	26,778		26,778			5,208
Disposal Group, Including Discontinued Operation, Other Liabilities	12,500		12,500			9,316
Disposal Group, Including Discontinued Operation, Liabilities	96,265		96,265			49,024
Disposal Group, Including Discontinued Operation, Revenue	50,342	30,442	93,738	59,943
Disposal Group, Including Discontinued Operation,Insurance Benefits, Claims And Reserves	24,341	22,152	53,865	40,560
Disposal Group, Including Discontinued Operation, General and Administrative Expense	7,394	6,150	14,850	13,004
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax	18,607	2,140	25,023	6,379
Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax	402	0	402	0
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax	0	0	0	0
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	18,205	2,140	24,621	6,379
Discontinued Operation, Tax Effect of Discontinued Operation	3,836	822	5,151	1,689
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	14,369	1,318	19,470	4,690
Pets Sale Member | Discontinued Operations
Disposal Group, Including Discontinued Operation, Assets
Disposal Group, Including Discontinued Operation, Cash And Invesments	144,688		144,688			149,844
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent	41,716		41,716			62,414
Disposal Group, Including Discontinued Operation, Other Assets	35,392		35,392			29,730
Disposal Group, Including Discontinued Operation, Assets	221,796		221,796			241,988
Disposal Group, Including Discontinued Operation, Liabilities
Disposal Group, Including Discontinued Operation, Policy Benefits And Claims	12,743		12,743			11,775
Disposal Group, Including Discontinued Operation,Unearned Premiums	6,080		6,080			5,629
Disposal Group, Including Discontinued Operation, Other Liabilities	5,092		5,092			9,511
Disposal Group, Including Discontinued Operation, Liabilities	23,915		23,915			$ 26,915
Disposal Group, Including Discontinued Operation, Revenue	33,080	20,407	61,999	37,838
Disposal Group, Including Discontinued Operation,Insurance Benefits, Claims And Reserves	18,442	11,098	34,374	20,459
Disposal Group, Including Discontinued Operation, General and Administrative Expense	14,592	7,855	26,796	14,515
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax	46	1,454	829	2,864
Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax	410	0	410	0
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax	74,534	0	74,534	0
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	74,170	1,454	74,953	2,864
Discontinued Operation, Tax Effect of Discontinued Operation	11,734	442	11,875	741
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	$ 62,436	$ 1,012	$ 63,078	$ 2,123

Earnings Per Share _Text Bloc_3

Earnings Per Share [Text Block]: Earnings Per Share, Schedule Of Net Income Attributable To Parent (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Details
Income from continuing operations attributable to IHC	$ (436)	$ (1,835)	$ (612)	$ (1,987)
Income from discontinued operations attributable to IHC	76,907	2,256	82,704	6,686
Net Income (Loss) Attributable to Parent	$ 76,471	$ 421	$ 82,092	$ 4,699

Cash and Cash Equivalents Dis_3

Cash and Cash Equivalents Disclosure: Schedule of Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Details
Cash and Cash Equivalents, at Carrying Value	$ 22,834	$ 31,923	$ 11,655
Restricted Cash	418		985
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations	3,773		11,563
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$ 27,025	$ 74,793	$ 24,203	$ 24,631

Investments in Debt and Marke_6

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Debt Securities, Available-for-sale [Table Text Block] (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale, Amortized Cost	$ 181,579	$ 207,853
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	3,386	4,708
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	1,256	1,842
Debt Securities, Available-for-sale	183,709	210,719
Corporate Debt Securities
Debt Securities, Available-for-sale, Amortized Cost	75,245	91,802
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	1,583	2,174
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	779	1,302
Debt Securities, Available-for-sale	76,049	92,674
Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale, Amortized Cost	3,071	3,439
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	118	146
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	5	2
Debt Securities, Available-for-sale	3,184	3,583
US Treasury Securities
Debt Securities, Available-for-sale, Amortized Cost	23,029	23,397
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	273	414
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0	0
Debt Securities, Available-for-sale	23,302	23,811
US Government Agencies Debt Securities
Debt Securities, Available-for-sale, Amortized Cost	35	39
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	4	5
Debt Securities, Available-for-sale	31	34
US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale, Amortized Cost	2,969	3,055
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	84	81
Debt Securities, Available-for-sale	2,885	2,974
US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale, Amortized Cost	74,086	82,910
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	1,261	1,768
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	384	452
Debt Securities, Available-for-sale	74,963	84,226
Debt Security, Government, Non-US
Debt Securities, Available-for-sale, Amortized Cost	3,144	3,211
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	151	206
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0	0
Debt Securities, Available-for-sale	$ 3,295	$ 3,417

Investments in Debt and Marke_7

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Investments Classified by Contractual Maturity Date (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Details
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost	$ 36,481
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value	36,938
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost	87,377
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value	89,128
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Amortized Cost	20,124
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value	20,292
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10	31,522
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10	31,252
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost	6,075
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value	6,099
Debt Securities, Available-for-sale, Amortized Cost	181,579	$ 207,853
Debt Securities, Available-for-sale	$ 183,709	$ 210,719

Investments in Debt and Marke_8

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Details) $ in Thousands	Jun. 30, 2021USD ($)	Dec. 31, 2020USD ($)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	$ 31,019	$ 41,356
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	825	615
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	16,202	17,927
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	431	1,227
Debt Securities, Available-for-sale, Unrealized Loss Position	47,221	59,283
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	$ 1,256	$ 1,842
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions	9	20
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions	14	13
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions	23	33
Corporate Debt Securities
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	$ 19,962	$ 23,591
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	740	458
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	4,503	8,845
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	39	844
Debt Securities, Available-for-sale, Unrealized Loss Position	24,465	32,436
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	779	1,302
Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	707	748
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	5	2
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	0	0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	0	0
Debt Securities, Available-for-sale, Unrealized Loss Position	707	748
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	5	2
US Government Agencies Debt Securities
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	31	34
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	4	5
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	0	0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	0	0
Debt Securities, Available-for-sale, Unrealized Loss Position	31	34
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	4	5
US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	0	0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	0	0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	2,886	2,974
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	84	81
Debt Securities, Available-for-sale, Unrealized Loss Position	2,886	2,974
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	84	81
US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	10,319	16,983
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	76	150
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	8,813	6,108
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	308	302
Debt Securities, Available-for-sale, Unrealized Loss Position	19,132	23,091
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	$ 384	$ 452

Investments in Debt and Marke_9

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Realized Gain (Loss) on Investments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Details
Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment	$ (126)	$ 50	$ 46	$ 284
Equity Securities, FV-NI, Realized Gain (Loss)	0	0	292	0
Debt and Equity Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment	(126)	50	338	284
Equity Securities, FV-NI, Unrealized Gain (Loss)	0	214	(247)	(184)
Debt and Equity Securities, Gain (Loss)	(126)	264	91	100
Gain (Loss) on Sale of Other Investments	0	10	0	17
Gain (Loss) on Investments	$ (126)	$ 274	$ 91	$ 117

Investments in Debt and Mark_10

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Details
Available-for-sale Securities, Gross Realized Gains	$ 61	$ 97	$ 254	$ 346
Available-for-sale Securities, Gross Realized Losses	$ 187	$ 47	206	62
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities			$ 0	$ 0

Fair Value Disclosures _Text _5

Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale	$ 183,709	$ 210,719
Equity Securities, FV-NI, Current	0	1,753
Corporate Debt Securities
Debt Securities, Available-for-sale	76,049	92,674
Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale	3,184	3,583
US Treasury Securities
Debt Securities, Available-for-sale	23,302	23,811
US Government Agencies Debt Securities
Debt Securities, Available-for-sale	31	34
US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale	2,885	2,974
US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale	74,963	84,226
Debt Security, Government, Non-US
Debt Securities, Available-for-sale	3,295	3,417
Fair Value, Recurring
Debt Securities, Available-for-sale	183,709	210,719
Assets, Fair Value Disclosure	183,709	212,472
Equity Securities, FV-NI, Current		1,753
Fair Value, Recurring | Corporate Debt Securities
Debt Securities, Available-for-sale	76,049	92,674
Fair Value, Recurring | Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale	3,184	3,583
Fair Value, Recurring | US Treasury Securities
Debt Securities, Available-for-sale	23,302	23,811
Fair Value, Recurring | US Government Agencies Debt Securities
Debt Securities, Available-for-sale	31	34
Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale	2,885	2,974
Fair Value, Recurring | US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale	74,963	84,226
Fair Value, Recurring | Debt Security, Government, Non-US
Debt Securities, Available-for-sale	3,295	3,417
Fair Value, Recurring | COMMON STOCK, AMOUNT
Equity Securities, FV-NI, Current		1,753
Fair Value, Inputs, Level 1 | Fair Value, Recurring
Debt Securities, Available-for-sale	0	0
Assets, Fair Value Disclosure	0	1,753
Equity Securities, FV-NI, Current		1,753
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Corporate Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US Treasury Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US Government Agencies Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Debt Security, Government, Non-US
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | COMMON STOCK, AMOUNT
Equity Securities, FV-NI, Current		1,753
Fair Value, Inputs, Level 2 | Fair Value, Recurring
Debt Securities, Available-for-sale	182,695	209,623
Assets, Fair Value Disclosure	182,695	209,623
Equity Securities, FV-NI, Current		0
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Corporate Debt Securities
Debt Securities, Available-for-sale	76,049	92,674
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale	3,184	3,583
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US Treasury Securities
Debt Securities, Available-for-sale	23,302	23,811
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US Government Agencies Debt Securities
Debt Securities, Available-for-sale	31	34
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale	2,885	2,974
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale	73,949	83,130
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Debt Security, Government, Non-US
Debt Securities, Available-for-sale	3,295	3,417
Fair Value, Inputs, Level 2 | Fair Value, Recurring | COMMON STOCK, AMOUNT
Equity Securities, FV-NI, Current		0
Fair Value, Inputs, Level 3 | Fair Value, Recurring
Debt Securities, Available-for-sale	1,014	1,096
Assets, Fair Value Disclosure	1,014	1,096
Equity Securities, FV-NI, Current		0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Corporate Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US Treasury Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US Government Agencies Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale	1,014	1,096
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Debt Security, Government, Non-US
Debt Securities, Available-for-sale	$ 0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | COMMON STOCK, AMOUNT
Equity Securities, FV-NI, Current		$ 0

Fair Value Disclosures _Text _6

Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Beginning Balance	$ 1,055	$ 1,214	$ 1,096	$ 1,251
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	(4)	(5)	(8)	(9)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(37)	(34)	(74)	(67)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Ending Balance	1,014	1,175	1,014	1,175
Gain (Loss) on Investments
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0	0	0	0
US States and Political Subdivisions Debt Securities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Beginning Balance	1,055	1,214	1,096	1,251
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	(4)	(5)	(8)	(9)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(37)	(34)	(74)	(67)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Ending Balance	1,014	1,175	1,014	1,175
US States and Political Subdivisions Debt Securities | Gain (Loss) on Investments
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	$ 0	$ 0	$ 0	$ 0

Fair Value Disclosures _Text _7

Fair Value Disclosures [Text Block] (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2021
Details
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	$ (4)	$ (8)

Fair Value Disclosures _Text _8

Fair Value Disclosures [Text Block]: Fair Value, by Balance Sheet Grouping (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Short-term Investments	$ 1,550	$ 1,568
Securities Purchased under Agreements to Resell	70,323	33,038
Deposit Contracts, Liabilities	142,155	141,376
Policyholder Account Balance	11,988	12,001
Estimate of Fair Value Measurement | Fair Value, Inputs, Level 1
Short-term Investments	1,550	1,568
Securities Purchased under Agreements to Resell	70,323	33,038
Deposit Contracts, Liabilities	0	0
Policyholder Account Balance	0	0
Estimate of Fair Value Measurement | Fair Value, Inputs, Level 2
Short-term Investments	0	0
Securities Purchased under Agreements to Resell	0	0
Deposit Contracts, Liabilities	142,155	141,376
Policyholder Account Balance	11,988	12,001
Reported Value Measurement
Short-term Investments	1,550	1,568
Securities Purchased under Agreements to Resell	70,323	33,038
Deposit Contracts, Liabilities	142,155	141,376
Policyholder Account Balance	$ 11,988	$ 12,001

Investments in and Advances t_2

Investments in and Advances to Affiliates, Schedule of Investments [Text Block] (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Income (Loss) from Equity Method Investments	$ 4	$ (356)	$ 64	$ (28)
Ebix Health Exchange Member | Selling, General and Administrative Expenses
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party	361	$ 423	762	899
Lead Generation Company Member | Selling, General and Administrative Expenses
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party				$ 1,507
Other Investments
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	2,022		2,022
Accounts Payable and Accrued Liabilities | Ebix Health Exchange Member
Due to Related Parties	$ 94		$ 94		$ 163

Business Combination Disclosu_3

Business Combination Disclosure (Details) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020	Apr. 30, 2020	Jan. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenues					$ 49,330	$ 56,455	$ 101,671	$ 113,522
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest					$ 76,368	$ 538	$ 81,934	4,860
Abacus
Business Acquisition, Percentage of Voting Interests Acquired		56.00%		56.00%
Business Combination, Consideration Transferred		$ 2,599
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value				$ 1,838
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss				163
Goodwill, Acquired During Period				4,662
Business Acquisition, Goodwill, Expected Tax Deductible Amount		2,725		2,725
Payments to Acquire Businesses, Gross				2,599
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net		$ (225)		$ (225)
Torchlight Technology Group Acquisition Member
Business Acquisition, Percentage of Voting Interests Acquired	77.00%		77.00%
Business Combination, Consideration Transferred			$ 11,628
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value			3,432
Goodwill, Acquired During Period			11,122
Business Acquisition, Goodwill, Expected Tax Deductible Amount	$ 7,976		7,976
Payments to Acquire Businesses, Gross	11,443
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net	3,938		3,938
Business Combination, Consideration Transferred, Liabilities Incurred	$ 185
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain			519
Finite-lived Intangible Assets Acquired			$ 2,700
Revenues								1,828
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest								$ (564)

Business Combination Disclosu_4

Business Combination Disclosure: Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Abacus
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other		$ 350
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets		350
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other		575
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities		575
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net		$ (225)
Torchlight Technology Group Acquisition Member
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other	$ 2,132
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets	5,165
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities	1,227
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net	3,938
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents	333
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	2,700
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other	$ 1,227

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets Disclosure [Text Block] (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Goodwill	$ 12,486		$ 12,486		$ 12,486
Intangible Assets, Net (Excluding Goodwill)	3,667		3,667		4,008
Amortization of Intangible Assets	179	$ 171	341	$ 224
Specialty Health Segment Member
Goodwill	$ 8,263		$ 8,263		8,263
Group Disability And Life Member
Goodwill					$ 4,223

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets, Gross	$ 8,083	$ 9,083
Finite-Lived Intangible Assets, Accumulated Amortization	4,893	5,552
Customer Relationships
Finite-Lived Intangible Assets, Gross	6,583	7,583
Finite-Lived Intangible Assets, Accumulated Amortization	4,599	5,385
Computer Software, Intangible Asset
Finite-Lived Intangible Assets, Gross	1,500	1,500
Finite-Lived Intangible Assets, Accumulated Amortization	$ 294	$ 167

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Indefinite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Indefinite-lived Intangible Assets (Excluding Goodwill)	$ 477	$ 477
Licensing Agreements
Indefinite-lived Intangible Assets (Excluding Goodwill)	$ 477	$ 477

Revenue from Contract with Cu_4

Revenue from Contract with Customer: Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Insurance Commissions and Fees	$ 4,944	$ 3,907	$ 11,079	$ 7,341
Commissions
Insurance Commissions and Fees	1,416	1,932	4,297	3,672
Administrative Fees
Insurance Commissions and Fees	80	581	177	1,069
Marketing Fees
Insurance Commissions and Fees	254	292	559	643
Enrollment Platform Fees
Insurance Commissions and Fees	529	455	1,029	973
Lead and Referral Fees
Insurance Commissions and Fees	2,633	588	4,945	854
Payment Plan, Application and Other Fees
Insurance Commissions and Fees	$ 32	$ 59	$ 72	$ 130

Revenue from Contract with Cu_5

Revenue from Contract with Customer (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Accounts Payable and Accrued Liabilities
Accrued Sales Commission, Estimated Expected Lifetime Commissions	$ 2,858	$ 2,362

Revenue from Contract with Cu_6

Revenue from Contract with Customer: Contract with Customer, Contract Asset, Contract Liability, and Receivable (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)
Details
Contract with Customer, Asset, after Allowance for Credit Loss	$ 7,760
Contract with Customer, Asset, Increase (Decrease) for Revenues Recognized During the Year	4,708
Contract With Customer Asset Increase (Decrease) For Revenue Recognized From Prior Periods	(418)
Contract with Customer, Asset, Decrease for Cash Received During the Year	(3,251)
Contract with Customer, Asset, after Allowance for Credit Loss	$ 8,799

Income Tax Disclosure _Text B_2

Income Tax Disclosure [Text Block] (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax			$ (74,534)	$ 0
Discontinued Operations
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax	$ 74,534	$ 0	74,534	$ 0
Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation			11,841
Pets Sale, PetPartners Transaction | Discontinued Operations
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax			74,534
AMICSubsidiariesMember
Operating Loss Carryforwards					$ 46,116
Deferred Tax Assets, Valuation Allowance					8,281
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount			8,281
AMICSubsidiariesMember | Pets Sale, PetPartners Transaction
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount			$ 8,281
AMIC Holdiings | Domestic Tax Authority
Operating Loss Carryforwards					$ 46,116

Liability for Future Policy B_4

Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Liability for Claims and Claims Adjustment Expense, Beginning Balance	$ 132,957	$ 135,483
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance	36,126	36,993
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance	96,831	98,490
Current Year Claims and Claims Adjustment Expense	48,609	54,797
Prior Year Claims and Claims Adjustment Expense	(9,799)	(6,726)
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	38,810	48,071
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year	15,268	16,053
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years	27,235	31,810
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid	42,503	47,863
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance	93,138	98,698
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance	34,677	35,339
Liability for Claims and Claims Adjustment Expense, Ending Balance	127,815	134,037
Specialty Health Segment, All Product Lines
Liability for Claims and Claims Adjustment Expense, Beginning Balance	31,680	35,530
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance	1,776	1,717
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance	29,904	33,813
Current Year Claims and Claims Adjustment Expense	16,631	24,522
Prior Year Claims and Claims Adjustment Expense	(4,634)	(1,972)
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	11,997	22,550
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year	4,461	7,064
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years	12,080	17,530
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid	16,541	24,594
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance	25,360	31,769
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance	1,161	1,802
Liability for Claims and Claims Adjustment Expense, Ending Balance	26,521	33,571
Group Disability Product Line
Liability for Claims and Claims Adjustment Expense, Beginning Balance	80,976	80,079
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance	22,472	23,322
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance	58,504	56,757
Current Year Claims and Claims Adjustment Expense	20,031	19,093
Prior Year Claims and Claims Adjustment Expense	(4,033)	(1,553)
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	15,998	17,540
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year	3,922	4,010
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years	11,488	12,125
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid	15,410	16,135
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance	59,092	58,162
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance	22,492	22,463
Liability for Claims and Claims Adjustment Expense, Ending Balance	81,584	80,625
Other Short Duration Contract Product Lines
Liability for Claims and Claims Adjustment Expense, Beginning Balance	20,301	19,874
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance	11,878	11,954
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance	8,423	7,920
Current Year Claims and Claims Adjustment Expense	11,947	11,182
Prior Year Claims and Claims Adjustment Expense	(1,132)	(3,201)
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	10,815	7,981
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year	6,885	4,979
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years	3,667	2,155
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid	10,552	7,134
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance	8,686	8,767
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance	11,024	11,074
Liability for Claims and Claims Adjustment Expense, Ending Balance	19,710	19,841
Health Insurance Product Line | Specialty Health Segment Member
Liability for Claims and Claims Adjustment Expense, Beginning Balance	28,295	31,259
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance	1,766	1,113
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance	26,529	30,146
Current Year Claims and Claims Adjustment Expense	15,818	23,627
Prior Year Claims and Claims Adjustment Expense	(3,658)	(1,184)
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	12,160	22,443
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year	4,319	8,260
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years	11,992	16,382
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid	16,311	24,642
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance	22,378	27,947
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance	1,158	1,406
Liability for Claims and Claims Adjustment Expense, Ending Balance	$ 23,536	$ 29,353

Liability for Future Policy B_5

Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule Of Prior Year Claims And Claims Adjustment Expense Disclosure (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Prior Year Claims and Claims Adjustment Expense	$ (9,799)	$ (6,726)
Specialty Health, Short-Term Medical Product Line
Prior Year Claims and Claims Adjustment Expense	(1,676)	(286)
Specialty Health, Occupational Accident Product Line
Prior Year Claims and Claims Adjustment Expense	(963)	(798)
Specialty Health, Fixed Indemnity Limited Benefit Product Line
Prior Year Claims and Claims Adjustment Expense	(862)	736
Specialty Health, Limited Medical Product Line
Prior Year Claims and Claims Adjustment Expense	(197)	(241)
Specialty Health, Critical Illness Product Line
Prior Year Claims and Claims Adjustment Expense	(196)	(397)
Specialty Health, Group Gap Product Line
Prior Year Claims and Claims Adjustment Expense	(356)	(513)
Specialty Health, Other Specialty Health Product Lines
Prior Year Claims and Claims Adjustment Expense	(384)	(473)
Specialty Health Segment, All Product Lines
Prior Year Claims and Claims Adjustment Expense	$ (4,634)	$ (1,972)

Liability for Future Policy B_6

Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Prior Year Claims and Claims Adjustment Expense	$ (9,799)	$ (6,726)
Group Disability Product Line
Prior Year Claims and Claims Adjustment Expense	(4,033)	(1,553)
Health Insurance Product Line | Specialty Health Segment Member
Prior Year Claims and Claims Adjustment Expense	(3,658)	$ (1,184)
Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net	$ 22,378

Stockholders' Equity Note Dis_4

Stockholders' Equity Note Disclosure [Text Block]: Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Accumulated other comprehensive income (loss)			$ 4,197
Other Comprehensive Income (Loss), Net of Tax	$ 952	$ 1,753	(977)	$ 1,642
Accumulated other comprehensive income (loss)	3,220		3,220
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent
Accumulated other comprehensive income (loss)	2,268	1,101	4,197	1,212
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	784	1,810	(1,013)	2,544
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	(168)	57	(36)	902
Other Comprehensive Income (Loss), Net of Tax	952	1,753	(977)	1,642
Accumulated other comprehensive income (loss)	$ 3,220	$ 2,854	$ 3,220	$ 2,854

Stockholders' Equity Note Dis_5

Stockholders' Equity Note Disclosure [Text Block]: Reclassification out of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Gain (Loss) on Investments	$ (126)	$ 274	$ 91	$ 117
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(704)	(2,858)	(1,044)	(3,140)
Income Tax Expense (Benefit)	(267)	(1,066)	(430)	(1,187)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	(437)	(1,792)	(614)	(1,953)
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	92,375	3,594	99,574	9,243
Discontinued Operation, Tax Effect of Discontinued Operation	15,570	1,264	17,026	2,430
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	76,805	2,330	82,548	6,813
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	76,368	538	81,934	4,860
Reclassification out of Accumulated Other Comprehensive Income | AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent
Gain (Loss) on Investments	(125)	47	47	284
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(125)	47	47	284
Income Tax Expense (Benefit)	(28)	10	9	60
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	(97)	37	38	224
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	(90)	25	(94)	858
Discontinued Operation, Tax Effect of Discontinued Operation	(19)	5	(20)	180
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	(71)	20	(74)	678
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (168)	$ 57	$ (36)	$ 902

Cash Flow, Supplemental Discl_2

Cash Flow, Supplemental Disclosures [Text Block] (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Details
Income Taxes Paid (Refunds), Net	$ 59	$ 55

Commitments and Contingencies_2

Commitments and Contingencies Disclosure [Text Block] (Details) - USD ($) $ in Thousands	1 Months Ended			3 Months Ended
	Oct. 31, 2020	Sep. 30, 2020	May 31, 2017	Sep. 30, 2020
Accounts Payable and Accrued Liabilities
Loss Contingency Accrual, Provision				$ 3,660
Loss Contingency Accrual, Payments	$ 3,660
Other Income
Gain (Loss) Related to Litigation Settlement		$ 5,641
Pending Litigation | Loss Contingency, Nature, Amounts Allegedly Owed To Plaintiff Member
Loss Contingency, Damages Sought, Value			$ 3,082

Segment Reporting Disclosure _3

Segment Reporting Disclosure [Text Block]: Schedule of Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenues	$ 49,330	$ 56,455	$ 101,671	$ 113,522
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(704)	(2,858)	(1,044)	(3,140)
Operating Segments
Revenues	49,456	56,181	101,580	113,405
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(578)	(3,132)	(1,135)	(3,257)
Segment Reconciling Items | Gain (Loss) on Investments
Revenues	(126)	274	91	117
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(126)	274	91	117
Specialty Health Segment Member
Revenues	23,862	30,718	50,133	62,924
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(841)	(5,329)	(2,732)	(5,935)
Group Disability And Life Member
Revenues	25,143	24,076	50,264	48,161
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	3,770	4,353	6,900	6,190
Individual life annuities and other Segment Member
Revenues	183	490	392	808
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(263)	(140)	(247)	(283)
Amortization of Other Deferred Charges	153	176	310	364
Corporate Segment
Revenues	268	897	791	1,512
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ (3,244)	$ (2,016)	$ (5,056)	$ (3,229)

Subsequent Events _Text Block_

Subsequent Events [Text Block] (Details) - MNL Sale - Discontinued Operations $ in Thousands	Jul. 14, 2021USD ($)
Disposal Group Including Discontinued Operation, Transaction Price	$ 172,500
Disposal Group Including Discontinued Operation, Transaction Price, Potential Earn Out	$ 12,500